Comparing U.S. Ebola Outbreak Response Capabilities and Practices Over Time

Published: Jul 28, 2026

The current Ebola outbreak centered in the Democratic Republic of the Congo (DRC), first identified in May 2026, has rapidly developed into the third largest Ebola outbreak on record. It presents particular challenges for responders because there are no readily available vaccines or treatments for the species of Ebola causing this outbreak, which is also taking place in a region with active conflict and multiple concurrent humanitarian crises. It is also the most significant international infectious disease outbreak the Trump administration has had to face in its second term. Given major changes made by the administration to U.S. global health and pandemic response mechanisms over the past year and half – including reducing funding, cutting staff, changing priorities and shuttering USAID – some have raised concerns that U.S. international disease response capacity has been compromised and the effectiveness of the U.S. response has been limited. Others have observed that the U.S. has, in comparison to previous Ebola responses, mobilized relatively quickly this time. To help put U.S. capacities and actions in further context, this analysis compares the current U.S. Ebola response to those of the two prior largest outbreaks – the West African outbreak of 2014-2015 and the DRC outbreak of 2018-20201 looking across a range of indicators and categories. Even so, such comparisons are complex, as there are many interrelated factors that affect any governmental response — including the severity and size of the outbreak itself, the response of other international and domestic actors, whether there are medical countermeasures available, and whether the outbreak is occurring under exceptionally difficult conditions, such as active conflict.

Taking these dimensions into consideration, this analysis finds that:

  • The speed of the U.S. government’s response to the current outbreak is on par with the prior two outbreaks. In all three cases, the U.S. mobilized an initial response, including funding and personnel, within days of cases first being reported.
  • Initial U.S. funding amounts are already surpassing the prior two outbreaks. The U.S. provided $21 million in the first six months of the West African outbreak, $98 million in the first year of the 2018-2020 DRC outbreak and has already pledged $375 million in the first two months of the current outbreak.  Given that it is still relatively early in the current outbreak, which could become protracted, final U.S. funding levels will likely grow; the administration has already asked Congress for emergency funding of $1.4 billion. 
  • Across all outbreak responses including the current response, the U.S. has consistently supported research and development (R&D) for Ebola countermeasures such as diagnostics, tests, treatments, and vaccines, which has been instrumental in identifying and testing new vaccine and treatment candidates; given that there is no vaccine or specific treatments for the current species of Ebola, this work is quite critical.
  • At the same time, a significant difference between current and past responses is in the U.S. organizational structure and approach, resulting from the changes made last year by the administration. Past responses were led by USAID and its Office of Foreign Disaster Assistance (OFDA), with a major role played by CDC. Given the dissolution of USAID in 2025, the response lead has shifted to the State Department and its Bureau of Global Health Security and Diplomacy (GHSD) and Bureau of Disaster and Humanitarian Response (DHR), both of which have seen their staffing reduced over the past year. Past responses also had White House National Security Council (NSC) level offices and staff with specific responsibilities for international infectious disease response coordination, something initially absent this time. The current relative lack of specified inter-departmental coordination mechanisms could affect the U.S. response over time, particularly if the outbreak is protracted and the U.S. response scales up further, although there are indications that the administration may seek to name an Ebola response coordinator.
  • In addition, while the U.S. has had pre-existing global health programs in these countries when each outbreak has occurred, the current U.S. response takes place after significant upheaval in U.S. global health programs, and as the administration implements its new America First Global Health Strategy, including through a new memorandum of understanding (MOU) the U.S. signed with the DRC in February, three months before the current outbreak was identified. That new agreement will reduce U.S. funding over time and shift financial and operational responsibility to the country.  
  • Another notable difference is in U.S. multilateral engagement. In the past, the U.S. was directly engaged with the World Health Organization (WHO) and synced to the strategic pillars identified by WHO and other partners in Ebola response plans. Having left WHO membership last year, the U.S. is, for the first time, not formally coordinating with the agency, although it is coordinating with other United Nations (UN) agencies including the Office for the Coordination of Humanitarian Affairs (OCHA), the International Organization for Migration (IOM), the World Food Programme (WFP), and the United Nations Children’s Fund (UNICEF). The lack of formal relations with WHO, however, could have implications as the response continues to unfold, and present barriers to communications or coordination at times.
  • There is also a marked difference in how the U.S. has approached domestic border protection in the current outbreak compared to the past. During prior outbreaks, the U.S. relied on country exit screening, screening at U.S. ports of entry, and follow-up monitoring of travelers from affected countries but not outright travel bans. At present, the administration has imposed a more restrictive posture barring incoming travelers altogether (U.S. citizens and non-citizens that have been in DRC within the last 21 days, as well as non-citizens that have been in Uganda or South Sudan in that time period).  

While it is still early to take full stock of the U.S. response to the current outbreaks, based on this analysis some key questions and areas to watch going forward include:

  • Will this escalate and potentially require more long-standing U.S. engagement?
  • Will the level of U.S. international engagement shift, particularly if the outbreak worsens significantly and/or spreads beyond DRC borders in a more substantial way?
  • If the outbreak does expand significantly, will the U.S. support greater mobilization of U.S. staff?
  • Will Congress appropriate emergency funding?
  • How might the outbreak affect other U.S. supported health efforts in the DRC including the recently signed MOU on global health?
  • What will happen with the approach to U.S. border security, especially if more Americans become infected? What other domestic response would be put in place if Ebola cases are identified in the U.S.?

Table 1. Comparing U.S. Responses to Three Ebola Outbreaks
2014-2015 West Africa
Ebola Outbreak
2018-2020 DRC
Ebola Outbreak
2026 DRC
Ebola Outbreak
Key Outbreak Characteristics
Date of initial case report/confirmationMarch 21, 2014
(First lab confirmed cases from Guinea)
August 1, 2018
(Outbreak declared by Democratic Republic of the Congo (DRC) Ministry of Health (MOH)

August 7 (lab confirmed cases reported).
May 5, 2026(DRC notified World Health Organization (WHO) of possible outbreak) 

May 15, 2026 (lab confirmed cases reported)
Date of first WHO Emergency Committee (EC) Meeting to Assess This OutbreakAugust 7, 2014October 17, 2018May 19, 2026
Date of Initial WHO “Public Health Emergency of International Concern (PHEIC) declarationAugust 8, 2014
(141 days after initial cases identified)
July 17, 2019
(almost 1 year after first case reports, due to the WHO EC initial determination the outbreak was not a regional threat, a key criteria for PHEIC determinations).
May 17, 2026
(16 days after first cases identified, 2 days after first cases confirmed).

PHEIC declaration was made by Director-General before Emergency Committee met.
Virus speciesZaireZaireBundibugyo
Primary countries affectedGuinea, Liberia, Sierra LeoneDRCDRC and Uganda
Total number of reported cases and deaths28,610 cases, 11,323 deaths over 28 months (outbreak declared over in June 2016)3,470 cases and 2,287 deaths over 22 months (outbreak declared over in June 2020)3,200 cases, 1405 deaths (over 8 weeks, through July 25, 2026)
Vaccine availabilityNo vaccine available initially. Clinical trials with candidate vaccines began in in West Africa in February and March 2015. A candidate vaccine was made available under a compassionate use protocol for broader community “ring vaccination” purposes in March 2016 in Guinea.Yes. Over 236,000 people vaccinated in DRC during the outbreak response.No vaccine availability at this time. Trials with candidate vaccines began in July 2026.
Therapeutics availabilityNo therapeutics available initially. Limited use of experimental therapeutics began in August 2014; clinical trials began in March 2015.Limited use of experimental therapeutics in 2018; a trial of several candidate treatments began November 2018.No therapeutics available at this time. Clinical trials of experimental candidates began in July 2026.
Active conflict/ instability in affected areasNoYesYes
U.S. Funding for Response
Speed of initial U.S. response funding

(time from outbreak detection to mobilization of U.S. response funds)
Initial U.S. Agency for International Development (USAID)/Office of Foreign Disaster Assistance (ODFA) funding provided in March 2014, soon after initial outbreak reports.

Centers for Disease Control and Prevention (CDC) supported initial staff deployments to affected areas in late March/early April. As the outbreak worsened considerably over subsequent months, U.S. funding scaled up, particularly from August 2014 on.
Initial USAID funding provided in August 2018, within weeks of the initial announcement of confirmed Ebola cases in eastern DRC. CDC also supported staff deployments and response activities in August

As outbreak worsened considerably in March/April 2019, U.S. response funding scaled up.
Initial funding announced on May 19.
(four days after initial case confirmation and two days after PHEIC declaration).
Amount and source of initial response fundingBetween March and August 2014, $21 million in cumulative response funding reported from USAID. By October 2014, CDC had committed >$16.7 million for its Ebola response activities. Initial funding drawn from USAID International Disaster Assistance fundsAs of September 5, 2018, USAID had provided at least $2 million for response activities. Over the first 11 months of the response (through July 2019) USAID reported $98 million in support for the response.  Funds drawn from unspent FY2015 Ebola emergency supplemental funds.State Department announced $23 million in initial Ebola response funding on May 19, drawn from existing FY2026 State Department humanitarian assistance funds. 
Total U.S. response funding amount and sourceApproximately $2 billion in U.S. international response funding obligated by the end of 2015, primarily through emergency/supplemental appropriations provided to USAID and CDC.From August 2018 to June 2020, USAID provided over $342 million for response activities, drawn from USAID International Disaster Assistance, USAID/Global Health, USAID/Food for Peace, and USAID Mission funds. USAID used unspent FY2015 Ebola emergency supplemental funds.$270 million was committed by the State Department as of June 12, drawn from State Department’s existing FY2026 humanitarian response funds. The U.S. has made an overall pledge of $375 million in support of the response as of June 19.
Emergency / supplemental funding requests and appropriationsWhite House requested $6.2 billion in emergency supplemental funding in November 2014. In December 2014, Congress appropriated $5.4 billion, including $3.7 for international response activities.None requested.
White House requested $1.4 billion in emergency supplemental funding in June 2026. As of July 2026, Congress had not yet appropriated additional funding.
U.S. funding share of overall international response funding The U.S. was the largest donor to the response, providing $2.4 billion (41%) of the $5.81 billion in overall donor funding provided between 2014 and 2016.The U.S. was the largest donor to the response, providing $252 million (34%) of the $734 million in overall donor funding provided between August 2018 and December 2019.The $375 million pledged $375 million by the US for Ebola response activities represents 41% of the $910 million in overall donor funding ‌pledges made by international donors in support of the joint continental Ebola response plan.
U.S. Staff Deployments, EOC Activation
Staff Mobilized/ DeployedPrior to the outbreak, USAID and CDC presence in the three most affected countries “very limited.” On March 31, 2014, a 5-person CDC team deployed to Guinea. In August 2014, 28-member DART team deployed (staff from USAID, CDC, the Department of Defense (DoD), other agencies).

By the end of the outbreak, over 3,500 personnel from DoD, CDC, U.S. Public Health Service (USPHS) Commissioned Corps, USAID, and National Institutes of Health (NIH) were deployed.
First 5 CDC staff deployed to North Kivu August 2018 (pulled back after a few days). By May 2019, CDC had 17 staff in Kinshasa and Goma. 

USAID established a DART team on September 21, 2018. 

During response, U.S. staff kept away from front lines due to security concerns.
CDC reports it has 23 field staff in DRC and over 100 staff in Uganda.

State Department has deployed an unknown number of staff from GHSD and DHR via DART to DRC and Uganda.
CDC Emergency Operations Center (EOC) ActivationEOC activated on July 9, 2014. (110 days after initial case confirmations).

On March 31, 2016, CDC officially deactivated the EOC for this response.
EOC activated in June 2019. (10 months after initial case confirmations).

The EOC was deactivated some time in 2020, no official announcement made.
EOC activated on May 17, 2026 (two days after case confirmations)

Raised to “highest alert level” June 26, 2026.
U.S. Organizational Approach
Agencies involved and coordinationUSAID/OFDA, CDC, DoD, NIH, and State Department. 

In May 2014, the White House asked the HHS Office of Global Affairs to coordinate the U.S. government response, with USAID as operational lead and CDC as lead on technical and public health issues. 

As the outbreak continued to expand in West Africa, and several Americans working in West Africa became infected with Ebola, President Obama became directly involved, offering to send U.S. troops in September, and appointing an Ebola Response Coordinator in October 2014 who eventually led coordination of U.S. agencies through a position at the National Security Council (NSC)
USAID/OFDA, CDC. 

No NSC-level leader designated for coordinating U.S. response, as the global health security team at NSC was disbanded in May 2018 during a reorganization process under the first Trump Administration. Primarily,  coordination occurred at the department/agency level.
USAID was dissolved in 2025, making the State Department the primary response agency along with CDC. At the State Department, the Bureau of Global Health Security and Diplomacy (GHSD), and Bureau of Disaster and Humanitarian Response (DHR) are the key bureaus overseeing response activities. 

No specific NSC GHS staff/office designated initially to provide coordination, though a director for bioresponse at the National Security Council was named in July. In June, Secretary of State Rubio stated the administration is considering naming an Ebola response coordinator to oversee the U.S. response.
Pre-existing U.S. Global Health Programs in Affected Countries
Amount of U.S. GH funding in affected countries in the fiscal year prior to initial outbreak

(amounts are disbursements for the indicated fiscal year)
In FY2014, U.S. GH funding by affected country was:
Guinea: $18.8 million, primarily for malaria and family planning/ reproductive health (FPRH), plus maternal and child health (MCH), and HIV/AIDS.
Liberia: $26.2 million, primarily malaria, MCH, and FPRH, plus HIV/AIDS, and Nutrition.
Sierra Leone: $750k for HIV/AIDS.
In FY2018, U.S. GH funding for DRC was $146.4 million, primarily for malaria, HIV/AIDS, MCH, FPRH, tuberculosis (TB), Global Health Security (GHS), and Nutrition. In FY2025, U.S. GH funding for DRC was $165.8 million, primarily for malaria, HIV/AIDS, MCH, FPRH, GHS, and Nutrition.
U.S. Communications Practices
USG public communications on Ebola responseRegular communications from USAID, CDC and other federal agencies on international response activities, domestic public health guidance. National press conferences and televised briefings were featured. Notable White House involvement in communications starting in August 2014 due to significant public interest in the topic following identification of Ebola cases in the U.S. USAID had the lead for communications regarding U.S. response operations in West Africa, while HHS (including CDC) and the National Security Council handled communications about domestic Ebola cases.Comparatively less U.S. public attention compared to 2014. Still, CDC and USAID provided situation updates, travel notices, technical guidance. WH public facing engagement was not apparent.

 

CDC has conducted media briefings, technical briefings, publication of updates, guidance, risk assessments. State Department has provided press conferences, semi-regular posts about U.S. activities and support. President Trump mentioned U.S. support for international response in public remarks.
U.S. Research & Development Support
U.S. support for countermeasures R&D, including vaccinesNIH provided accelerated early clinical trials of vaccine candidates, and field efficacy studies in Guinea and Liberia. U.S. supported evaluation of several experimental therapies, including ZMapp, TKM-Ebola, Favipiravir, and convalescent plasma.  NIH supported ZMapp investigational treatment R&D in DRC.The rVSV Ebola vaccine was used extensively during the response, under expanded-access, with the U.S. supporting vaccine logistics, effectiveness monitoring, operational research, ring vaccination strategy, and other related activities.  U.S. research response has focused on evaluating cross-protection of existing vaccines/treatments, development of multivalent vaccine candidates.USG committed $50 million to the Coalition for Epidemic Preparedness Innovations (CEPI) to advance Bundibugyo vaccine R&D.

BARDA/Mapp Biopharmaceutical announced a transfer of investigational doses of MBP134 monoclonal antibody to DRC. 
U.S. Multilateral Engagement
U.S. multilateral engagement on response activitiesThe U.S. led much of the response, especially in the early stages in 2018, as the WHO-led multilateral response took time to scale up. U.S. response primarily bilateral, with a focus particularly on supporting activities in Liberia 

As the multilateral response expanded, the U.S. engaged as active, partner for WHO, UN agencies, and the UN special mission for Ebola response known as UNMEER that was created in September 2014. U.S. activities and engagement spanned all major “response pillars” outlined in multilateral response plans. The U.S. was the largest donor to WHO’s Ebola response activities, providing $73.9 million, and largest donor overall to Ebola response in the region.
The U.S. played an important, though more supporting role as WHO and the DRC government primarily led the response. U.S. activities supported the Ebola response plan developed by DRC, WHO and other international partners. U.S. agencies (including NIH, USAMRIID, and CDC) as well as U.S. funded NGOs were listed as supporting partners across most of the response sectors/pillars, though the U.S. CDC was the only U.S. agency listed as a co-lead (along with WHO) for one of the main response pillars (“Health Information and Analytics”).Following U.S. withdrawal as a WHO member state, communication and engagement with WHO is limited. The U.S. has direct engagement with UN humanitarian response organizations including OCHA, WFP, UNICEF. The multisectoral continental response plan released by DRC, WHO, and Africa CDC lists the following USG entities as partners across response activities: CDC as co-lead for the surveillance and epidemiology & laboratory systems and genomic sequencing response pillars, and NIH as a partner organization for the clinical trials/R&D sub-pillar.
Domestic border protection measures
U.S. government border policies during Ebola responseFocused on exit screening of travelers from at-risk countries, and entry risk assessment and management for incoming travelers. Travelers from West Africa were primarily directed through five US airports where they went through CDC-designed screening and follow-up with active monitoring of at-risk contacts. In limited cases, there were state-imposed quarantines/isolation.CDC implemented routine border health security measures at ports of entry. No additional measures imposed.The U.S. has barred entry for all travelers on commercial flights who were recently in DRC – including U.S. citizens – and non-U.S. citizen travelers who were recently in Uganda or South Sudan. U.S. officials have stated they do not wish to repatriate any Americans who become infected with Ebola overseas. Already, two U.S. citizen health care workers infected with Ebola in DRC have been transported to Germany for monitoring and treatment, rather than brought to the U.S., and seven American aid workers working on the Ebola response in DRC have been sent to a facility in Kenya to quarantine rather than allowed to return to the U.S. immediately.

  1. There was an earlier, smaller Ebola outbreak in 2018 in the northwestern Equateur Province in DRC, initially identified in May 2018. The Equateur outbreak was contained by the end of July 2018, just weeks before the before another, separate, and eventually much larger, outbreak was identified in the Ituri Province in eastern DRC in August 2018. This analysis does not examine the U.S. response to the Equateur outbreak. ↩︎
Poll Finding

KFF Health Tracking Poll: Ebola & Pandemic Preparedness

Published: Jul 28, 2026

Findings

In May, authorities confirmed an Ebola outbreak centered in the Democratic Republic of the Congo (DRC), which has since grown to become the third largest Ebola outbreak on record, causing more than 2,000 cases and 750 deaths as of July. The State Department has announced the U.S. would provide “$270 million in direct Ebola response funding” and other support to assist the international response. This response from the Trump administration, however, comes amid a changed global and domestic health landscape, marked by reduced U.S. foreign aid funding and the dissolution of USAID, as well as cuts to domestic public health programs.

The latest KFF Health Tracking Poll finds many adults have yet to form an opinion on the U.S. government’s response to the Ebola outbreak in the Democratic Republic of the Congo, though among those with a view, more say the government is falling short than say it is doing enough.

About four in ten adults (38%) say the U.S government is not doing enough to prevent an Ebola outbreak in the U.S., while one in four (23%) say the government is doing enough and 39% say they are not sure. Views are similar when it comes to the U.S. role abroad, with four in ten (40%) saying the government is not doing enough to help fight the outbreak in Africa, while one in five (18%) say the government is doing enough and 42% say they are not sure.

Across partisans, Democrats are more critical of the U.S. government’s Ebola response with majorities saying it is not doing enough to prevent an outbreak in the U.S. (58%) nor to help fight the outbreak in Africa (66%). Notably, about four in ten independents and Republicans say they are not sure if the U.S. is doing enough to prevent an Ebola outbreak in the U.S. and about half of both groups are unsure if the government is doing enough to help fight the outbreak in Africa.

Stacked bar chart showing share of adults who think the U.S. government is doing enough or not doing enough to prevent an Ebola outbreak in the U.S. and help fight the current Ebola outbreak in Africa. Shown among total adults and by party identification. Four in ten adults say the U.S. is either not doing enough or they are unsure. Adults are split in their answers by partisanship, though large shares of independents and Republicans are unsure.

Several years after the height of the COVID-19 pandemic and amid recent changes to federal health agencies and global health engagement during President Trump's second term, the public holds mixed views on whether the U.S. government is prepared for another pandemic or widespread health crisis. A plurality of adults (40%) say the U.S. government is “less prepared” to deal with a pandemic now than it was in 2020, while about a third (34%) say the government is now “more prepared,” and one in four say it is “just as prepared” as it was in 2020. Views are divided across partisan lines. While two-thirds of Democrats (67%) say the U.S. government is now “less prepared,” a majority of Republicans (56%) say the country is now more prepared for a pandemic. About four in ten independents (41%) say the U.S. is “less prepared” for a pandemic compared to 2020, while about a third (32%) say it is “more prepared.”

Republicans and Republican-leaning independents who identify as supporters of the Make America Great Again (MAGA) movement are the most confident; six in ten (61%) of them say the U.S. is “more prepared” to deal with a pandemic now than in 2020, compared to about half (47%) of their non-MAGA counterparts who say the same.

Stacked bar chart showing share of adults who think the U.S. government is now more prepared, less prepared, or just as prepared to deal with another pandemic or widespread health crisis compared to 2020. Shown among total adults and by party identification. One third of total adults think the U.S. is now more prepared to deal with another pandemic, though views diverge by partnership. Large shared of Republicans and MAGA supporters think the U.S. is now more prepared, while Democrats and independents think the U.S. is now less prepared to deal with a pandemic compared to 2020.

Compared to views shortly before the start of the second Trump administration, the public overall now takes a dimmer view of the U.S. government’s pandemic preparedness, though Republicans’ views have moved in the opposite direction. The share of the public who say the U.S. government is now less prepared to deal with another pandemic than it was in 2020 is up 14 percentage points since January 2025, before the Trump administration made significant changes to U.S. foreign aid efforts (40%, up from 26%). This increase is driven largely by Democrats, two-thirds (67%) of whom now say the U.S. is "less prepared" — an increase of 40 percentage points from early last year. Independents are also now more likely to say the U.S. is “less prepared” (41%, up from 23% in January 2025).

Republicans’ views, on the other hand, have shifted in the opposite direction. The share of Republicans who say the government is "more prepared" for a pandemic has increased 12 percentage points since January 2025 (56%, up from 44%), while fewer Republicans now view the U.S. as “less prepared” (14%, down from 27%).

Stacked bar chart showing share of adults who think the U.S. government is now more prepared, less prepared, or just as prepared to deal with another pandemic or widespread health crisis compared to 2020. Results shown for July 2026 and January 2025. Shown among total adults and by party identification. Large shares of total adults, Democrats and independents now say the U.S. is less prepared to deal with another pandemic compared to 2020 than when asked in 2025. A majority of Republicans say the U.S. is now more prepared to deal with another pandemic or widespread health crisis compared to 2020 than when asked in 2025.

Methodology

This KFF Health Tracking Poll/ KFF Tracking Poll on Health Information and Trust was designed and analyzed by public opinion researchers at KFF. The survey was conducted June 25 – June 30, 2026, online and by telephone among a nationally representative sample of 1,321 U.S. adults in English (n=1,238) and in Spanish (n=83). The sample includes 1,015 adults (n=69 in Spanish) reached through the SSRS Opinion Panel either online (n=990) or over the phone (n=25). The SSRS Opinion Panel is a nationally representative probability-based panel where panel members are recruited randomly in one of two ways: (a) Through invitations mailed to respondents randomly sampled from an Address-Based Sample (ABS) provided by Marketing Systems Groups (MSG) through the U.S. Postal Service’s Computerized Delivery Sequence (CDS); (b) from a dual-frame random digit dial (RDD) sample provided by MSG. For the online panel component, invitations were sent to panel members by email followed by up to three reminder emails. 

Another 306 (n=14 in Spanish) adults were reached through random digit dial telephone sample of prepaid cell phone numbers obtained through MSG. Phone numbers used for the prepaid cell phone component were randomly generated from a cell phone sampling frame with disproportionate stratification aimed at reaching Hispanic and non-Hispanic Black respondents. Stratification was based on incidence of the race/ethnicity groups within each frame. Among this prepaid cell phone component, 142 were interviewed by phone and 164 were invited to the web survey via short message service (SMS). 

Respondents in the prepaid cell phone sample who were interviewed by phone received a $15 incentive via a check received by mail or an electronic gift card incentive. Respondents in the prepaid cell phone sample reached via SMS received a $10 electronic gift card incentive. SSRS Opinion Panel respondents received a $5 electronic gift card incentive (some harder-to-reach groups received a $10 electronic gift card). In order to ensure data quality, cases were removed if they failed two or more quality checks: (1) attention check questions in the online version of the questionnaire, (2) had over 30% item non-response, or (3) had a length less than one quarter of the mean length by mode. Based on this criterion, 1 case was removed. 

The combined cell phone and panel samples were weighted to match the sample’s demographics to the national U.S. adult population using data from the Census Bureau’s 2025 Current Population Survey (CPS), September 2023 Volunteering and Civic Life Supplement data from the CPS, and the 2026 KFF Benchmarking Survey with ABS and prepaid cell phone samples. The demographic variables included in weighting for the general population sample are gender, age, education, race/ethnicity, region, civic engagement, frequency of internet use and political party identification. The weights account for differences in the probability of selection for each sample type (prepaid cell phone and panel). This includes adjustment for the sample design and geographic stratification of the cell phone sample, within household probability of selection, and the design of the panel-recruitment procedure. 

The margin of sampling error including the design effect for the full sample is plus or minus 3 percentage points. Numbers of respondents and margins of sampling error for key subgroups are shown in the table below. For results based on other subgroups, the margin of sampling error may be higher. Sample sizes and margins of sampling error for other subgroups are available on request. Sampling error is only one of many potential sources of error and there may be other unmeasured error in this or any other public opinion poll. KFF public opinion and survey research is a charter member of the Transparency Initiative of the American Association for Public Opinion Research. 

GroupN (unweighted)M.O.S.E.
Total1,321± 3 percentage points

Democrats426± 6 percentage points
Independents439± 6 percentage points
Republicans358± 6 percentage points

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2025

Published: Jul 27, 2026

Overview

This report, Donor Government Funding for HIV in Low- and Middle-Income Countries in 2025, tracks funding levels of the donor governments that collectively provide the bulk of international assistance for AIDS through bilateral programs and contributions to multilateral organizations. The new report, produced as a partnership between KFF and UNAIDS, provides the latest data available on donor funding disbursements based on data provided by governments. It includes their bilateral assistance to low- and middle-income countries and contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria as well as UNITAID.

Key Findings

Donor government funding for the HIV response in low-and middle-income countries fell substantially in 2025, its largest drop since the donor government funding scale-up to address HIV began, with funding dipping to pre-2008 levels. The decline was driven by reductions in disbursements from the United States, the largest donor to HIV in the world; aggregate funding from all other donors remained flat (even after adjusting for exchange rate fluctuations). This report, which focuses on both bilateral and multilateral funding for HIV provided by donor governments, provides the first analysis of the extent of this decline, comparing funding levels in 2025 to 2024 and examining broader funding trends over the past 15 years. Key findings are as follows:

  • Donor government funding for HIV decreased by US$2.1 billion, or 25%, in 2025 compared to the prior year. Disbursements totaled US$6.2 billion in 2025 compared to US$8.3 billion in 2024. This was the lowest level of donor government support since 2007 (US$5.0 billion).1, 2, 3
  • Both bilateral and multilateral funding from donor governments decreased. Bilateral funding declined by US$1.5 billion (26%) and multilateral funding declined by US$581 million (23%).
  • U.S. disbursements for HIV were US$2.1 billion less in 2025 compared to 2024 (US$4.6 billion compared to US$6.7 billion). The U.S. declines were due to significant changes made by the current U.S. administration to foreign assistance programs, including global health and HIV. At the same time, the U.S. Congress has continued to appropriate funding for HIV at steady levels, meaning that additional funding remains in the U.S. pipeline, although the extent to which those funds will be fully spent remains uncertain.
  • While HIV funding provided by all other donor governments was flat in 2025, the longer trend shows a decline, resulting in the U.S. shouldering an increasing share of the funding burden. Excluding the U.S., funding from all other donor governments totaled US$1.6 billion in 2025 compared to US$3.2 billion in 2011, a decrease of nearly 50%, largely due to declining bilateral support from other donor governments.  As a result, the U.S. share of total donor government funding for HIV rose from 59% in 2011 to 74% in 2025 making it increasingly vulnerable to changes in U.S. support as was seen in 2025. 
  • Future funding prospects are uncertain. The Organisation for Economic Co-operation and Development (OECD) Development Assistance Committee (DAC), which reported a 23% decrease in official development assistance (ODA) in 2025, has projected ODA will decrease again in 2026. Whether donor governments provide additional funding for HIV in the future, the significant reductions in 2025 have already affected the HIV response. While the U.S., the world’s largest donor for HIV, has begun to speed up obligations – agreements that will result in disbursements in the future, and the U.S. Congress has continued to appropriate funding at prior year levels, the America First Global Health Strategy calls for a significant reduction in funding to countries over a five-year period. As such, the extent to which all appropriated U.S. funds will be spent remains uncertain. In addition, the longer trend shows that funding from most other donor governments is on the decline, having already decreased by 50% since 2011.

Report

Introduction

This report provides the latest available data on donor government resources provided to address HIV in low- and middle-income countries, reporting on disbursements made in 2025. It is part of a collaborative tracking effort between UNAIDS and KFF that began almost 20 years ago, just as new global initiatives were being launched to address the epidemic. The analysis includes data from all 34 members of the Organisation for Economic Co-operation and Development (OECD)’s Development Assistance Committee (DAC), as well as non-DAC members who report data to the DAC. Data are collected directly from donor governments, UNAIDS, the Global Fund, and Unitaid, and supplemented with data from the DAC. Of the 34 DAC members, fifteen provide 98% of total disbursements for HIV; data for these donors are presented individually. For the remaining 19 DAC members, data are provided in aggregate. All totals are presented in current U.S. dollars (amounts are not adjusted for inflation). Totals include both bilateral and multilateral assistance. Multilateral assistance for HIV includes disbursements by donors to the Global Fund and Unitaid, adjusted for an estimated HIV share, and to UNAIDS. Overall trend data are provided for the 2002 to 2025 period). Disaggregated data on bilateral and multilateral amounts are provided starting in 2011 (see methodology for more detail).

The data for 2025 represent one of the first assessments of the financial impact of major changes made by the United States starting last year, including a freezing and then canceling of numerous global HIV projects, eliminating the U.S. Agency for International Development (USAID), and introducing a new approach, the America First Global Health Strategy, with plans to significantly scale-down U.S. support for countries over the next few years.   

Findings

Total Funding

In 2025, donor government funding for HIV through bilateral and multilateral channels totaled US$6.2 billion in current USD.4 This is a decrease of US$2.1 billion (25%) compared to 2024 (US$6.2 in 2025 compared to US$8.3 billion in 2024), marking the largest drop since the donor government funding scale-up began and the lowest level of funding since 2007 ($5.0 billion) (See Figure 1 and Table 1). Donor governments accounted for more than one-third of the UNAIDS estimated US$17.6 billion made available from all sources to address HIV in 2025, an 18% decline compared to the total resources available in 2024.5,6

HIV Funding from Donor Governments, 2002-2025 (Column Chart)
Donor Government Funding for HIV (bilateral & multilateral), 2011-2025 (current USD in millions) (Table)

The decrease in 2025 was due to a decline in disbursements, or payouts, by the United States following the current administration’s actions that fundamentally altered U.S. foreign assistance programs. Collectively, these actions temporarily halted, and then slowed, U.S. HIV disbursements in 2025. Although, these declines in U.S. HIV disbursements were not as steep as overall decreases in U.S. development assistance as reported by the OECD DAC.7 At the same time, the U.S. Congress has continued to appropriate funding for HIV at steady levels, meaning that additional funding remains in the U.S. pipeline and could be spent in the future. Still, the extent to which the administration will spend these funds is unknown and the administration’s America First Global Health Strategy calls for significant scale-down in U.S. funding for countries in the future, including an estimated $7.3 billion decline over the next five years, compared to the prior five-year period.

Although there were some fluctuations by other donors, in the aggregate, their HIV funding remained flat in 2025 (US$1.6) compared to 2024. Still, when the U.S. is removed, the longer trend shows that funding for HIV provided by other donor governments has been on the decline and is significantly below funding provided in 2011 (US$3.2 billion), a decrease of nearly 50%, largely due to declining bilateral support from other donor governments (See Figure 2).8

HIV Funding from Donor Governments, Other than the United States, 2011-2025 (Line chart)

Despite the decline, the United States continued to be the largest donor to HIV efforts, providing US$4.6 billion and accounting for 74% of total donor government funding in 2025.9 The second largest donor was France (US$280 million, 4%), followed by the U.K. (US$213 million, 3%), Japan (US$202 million, 3%), and Germany (US$200 million, 3%).10,11

Bilateral Disbursements

Bilateral disbursements for HIV – that is, funding disbursed by a donor on behalf of a recipient country or region – totaled US$4.3 billion in 2025, a decrease of US$1.5 billion (-26%) compared to 2024 (US$5.8 billion). The decline was due to decreased bilateral funding by the U.S., which disbursed US$3.9 billion in 2025, a decline of US$1.5 billion (28%) compared to 2024 (US$5.4 billion). As noted above, while the U.S. Congress has continued to appropriate funding for HIV, and the administration could choose to disburse additional funds in the future, the extent to which this will occur is unknown (See Figure 3).12,13

Bilateral HIV Funding from the United States, Appropriations vs. Disbursements, 2005-2025 (Line chart)

When the U.S. is removed, bilateral disbursements from all other donor governments totaled US$373 million in 2025, a slight increase compared to 2024 (US$368 million). Almost all other donor governments either increased slightly (Australia, Canada, Italy, Norway, Spain, and Sweden), or remained flat (Denmark, Ireland, Japan, the Netherlands, and the U.K.); bilateral funding from France and Germany declined. These trends were the same after accounting for exchange rate fluctuations.

Looking more broadly, bilateral funding from these donor governments (excluding the U.S.) declined by US$1.3 billion, or 78%, between 2011 (US$1.7 billion) and 2025 (US$373 million) (See Figure 2).

Multilateral Contributions

Multilateral contributions from donor governments to the Global Fund, Unitaid, and UNAIDS for HIV – funding disbursed by donor governments to these organizations which in turn use some (Global Fund and Unitaid) or all (UNAIDS) of that funding for HIV – totaled US$1.9 billion in 2025 (after adjusting for an HIV share to account for the fact that the Global Fund and Unitaid address other areas). This represents a decrease of US$581 million (23%) compared to 2024 (US$2.5 billion).14,15  While contributions to the Global Fund accounted for most of this decline - decreasing by US$470 million (21%) between 2025 (US$1.8 billion) and 2024 (US$2.3 billion), funding for UNAIDS was reduced by US$109 million (65%) in 2025 (US$60 million) compared to 2024 (US$169 million) as several donor governments eliminated or significantly reduced support; contributions to Unitaid were flat (US$57 million in 2025 compared to US$59 million in 2024).

The decrease in 2025 multilateral disbursements was primarily driven by the U.S., which provided US$672 million in 2025, a decline of nearly half ($588 million or 47%) the amount provided in 2024 (US$1.3 billion). This decline was due in part to the timing of U.S. payments to the Global Fund (per U.S. policy requirements, U.S. contributions cannot exceed 33% of total contributions to the Global Fund, resulting in significant year-to-year differences depending on the amounts other donors have provided),16 but also to a reduction in U.S. payments to the Global Fund last year, even where they were matched by other donor contributions. The U.S. also eliminated its support to UNAIDS in 2025 (U.S. funding totaled US$50 million in 2024). As with bilateral support, appropriated funds remain and the administration could choose to provide this funding in the future (See Figure 4).17

United States funding for the Global Fund, Appropriations vs. Disbursements, 2005-2025 (Line chart)

While there were fluctuations among some of the other donor governments, these changes were largely due to the timing of payments to the Global Fund that coincide with pledge periods and donor decisions about when to fulfill pledges. When the U.S. is removed, multilateral funding from all other donor governments totaled US$1.2 billion in 2025, matching the prior year level.

Most donor governments (eleven of the fifteen profiled in 2025) provide the majority of their HIV funding through multilateral organizations. Only Denmark, the Netherlands, the U.K., and the U.S. provide a larger share bilaterally (See Figure 5). While the U.K. provided most of its HIV funding bilaterally in 2025 (and 2024), this was entirely due to the timing of payments to the Global Fund. The U.K. fulfilled almost its entire pledge to the Global Fund for 2023-2025 in 2023 resulting in significantly lower levels of multilateral funding in both 2024 and 2025. In fact, between 2019-2023, most HIV funding from the U.K. was provided through multilateral channels.

HIV Funding from Donor Governments by Funding Channel, 2025 (Stacked column chart)

Fair Share

There are different ways to measure donor government contributions to HIV, relative to one another. While the U.S. government provides the largest amount of funding for HIV, for example, it also has the largest economy in the world. To assess relative contributions, or “fair share”, two measures were used: ranking by overall funding amount and ranking by funding for HIV per US$1 million GDP, to adjust for the size of donor economies (See Table 2):

  • Rank by share of total donor government funding for HIV: By this measure, the U.S. ranked first in 2025, followed by France, the U.K., Japan, and Germany. The U.S. has ranked #1 in absolute funding amounts since tracking efforts began.
  • Rank by funding for HIV per US$1 million GDP: By this measure, the Netherlands ranks first, followed by the U.S., Denmark, Norway, and France (See Figure 6).18
Assessing Fair Share Across Donor Governments, 2025 (Table)
Donor Government Ranking by Funding for HIV per US Million GDP, 2025 (Bar Chart)

Looking Forward

Future funding prospects are uncertain. While the current administration could choose to disburse additional funds, the extent to which they will do so is unclear. Moreover, the stated strategy of the administration is to reduce, and in some cases eliminate, U.S. funding to countries as these countries take on an increasing level of financial and operational responsibility. More broadly, the OECD DAC reported a 23% decrease in official development assistance (ODA) in 2025 and is projecting further decreases in 2026; while largely driven by the U.S., other donor governments have also reduced their development assistance.

This work was supported in part by the Joint United Nations Programme on HIV and AIDS (UNAIDS) and the Bill & Melinda Gates Foundation. KFF maintains full editorial control over all of its policy analysis, polling, and journalism activities.

Adam Wexler, Jen Kates, and Stephanie Oum are with KFF. Joint United Nations Programme on HIV and AIDS (UNAIDS).

Methods

This project represents a collaboration between the Joint United Nations Programme on HIV/AIDS (UNAIDS) and KFF. Data provided in this report were collected and analyzed by UNAIDS and KFF.

Totals presented in this analysis include both bilateral funding for HIV in low- and middle-income countries, core contributions to UNAIDS, and the estimated share of donor government contributions to the Global Fund and Unitaid that are used for HIV. Amounts are based on analysis of data from the 34 donor government members of the Organisation for Economic Co-operation and Development (OECD) Development Assistance Committee (DAC) in 2024 who had reported Official Development Assistance (ODA). Bilateral and multilateral data were collected from multiple sources. Disaggregated bilateral and multilateral data are only available starting from 2011.

Data on gross domestic product (GDP) were obtained from the International Monetary Fund’s World Economic Outlook Database and represent current price data for 2025 (see: https://data.imf.org/en/datasets/IMF.RES:WEO).

Bilateral Funding:

Bilateral funding is defined as any earmarked (HIV-designated) amount, including earmarked non-core (“multi-bi”) contributions to multilateral organizations, such as UNAIDS. Data included in this report represent funding assistance for HIV prevention, care, treatment and support activities, but do not include funding for international HIV research conducted in donor countries (which is not considered in estimates of resource needs for service delivery of HIV-related activities).

The research team collected the latest bilateral funding data directly from twelve governments: Australia, Canada, Denmark, France, Germany, Ireland, Japan, the Netherlands, Norway, Sweden, the United Kingdom, and the United States during the first half of 2026, representing the fiscal year 2025 period. Direct data collection from these donors was desirable because they represent the preponderance of donor government assistance for HIV and the latest official statistics – from the Organisation for Economic Co-operation and Development (OECD) Creditor Reporting System (CRS) (see: http://www.oecd.org/dac/stats/data)  – are from 2024 and do not include all forms of international assistance (e.g., certain funding streams provided by donors, such as HIV components of mixed-purpose grants to non-governmental organizations). Bilateral estimates for Ireland and Japan for 2025 were not available at the time of publication. Prior year bilateral totals for these two donor governments were used as preliminary estimates that will be updated once data are available. Data for all other member governments of the OECD DAC – Austria, Belgium, the Czech Republic, the European Commission, Estonia, Finland, Greece, Hungary, Iceland, Italy, Korea, Lithuania, Luxembourg, New Zealand, Poland, Portugal, the Slovak Republic, Slovenia, Spain, and Switzerland – which collectively accounted for less than 5 percent of bilateral disbursements in each of the past several years, were obtained from the OECD CRS database and are from calendar year 2024.

In 2025, France provided data revising prior year amounts to account for “set-aside” funding (adjusted for an HIV-share) that supports Global Fund related activities. While this funding is considered part of France’s pledge to the Global Fund, it is not counted by the Global Fund as a direct contribution and is instead included under bilateral totals in this analysis. Due to this update, amounts presented in this report will differ from prior reports. The U.K. provided a revised estimate for bilateral funding in 2024 following the release of the previous report “Donor Government Funding for HIV in Low- and Middle-Income Countries in 2024”. The 2024 total for the U.K. has been adjusted in this report.

Where donor governments were members of the European Union (EU), the research team ensured that no double-counting of funds occurred between EU Member State reported amounts and European Commission (EC) reported amounts for international HIV assistance. Figures obtained directly using this approach should be considered as the upper bound estimation of financial flows in support of HIV-related activities.

Reflecting deliberate strategies of integrating HIV activities into other activity sectors, some donors use policy markers to attribute portions of mixed-purpose projects to HIV. This is done, for example, by the Netherlands and the U.K. The bilateral figures submitted by the UK Foreign, Commonwealth & Development Office (FCDO) for the financial year 2025/26 are based on an existing FCDO ‘HIV policy marker’. Denmark also attributes percentages of multipurpose projects to HIV. Canada breaks its mixed-purpose projects into components by percentage. Germany, Norway, and Sweden provided data much more conservatively, consistent with DAC constructs and purpose codes. Apart from targeted HIV/AIDS programs, bilateral health programs mainly focusing on health systems strengthening are also designed to contribute to the HIV response in partner countries.

Bilateral assistance data represent disbursements. A disbursement is the actual release of funds to, or the purchase of goods or services for, a recipient. Disbursements in any given year may include disbursements of funds committed in prior years and in some cases, not all funds committed during a government fiscal year are disbursed in that year. In addition, a disbursement by a government does not necessarily mean that the funds were provided to a country or other intended end-user.

Amounts presented are for the fiscal year period, which varies by country. The U.S. fiscal year runs from October 1-September 30. The fiscal years for Canada, Japan, and the U.K. are April 1-March 31. The Australian fiscal year runs from July 1-June 30. The European Commission, Denmark, France, Germany, Italy, Ireland, the Netherlands, Norway, and Sweden use the calendar year. The OECD uses the calendar year, so data collected from the CRS for other donor governments reflect January 1-December 31. Most UN agencies use the calendar year, and their budgets are biennial.

All data are expressed in current US dollars (USD), unless otherwise noted. Where data were provided by governments in their currencies, they were adjusted by average daily exchange rates to obtain a USD equivalent, based on foreign exchange rate historical data available from the U.S. Federal Reserve (see: http://www.federalreserve.gov/) or the OECD.

Funding totals presented in this analysis should be considered preliminary estimates based on data provided and validated by representatives of the donor governments who were contacted directly.

Multilateral Funding:

Multilateral funding includes core contributions to UNAIDS, as well as contributions to the Global Fund (see: http://www.theglobalfund.org/en/) and Unitaid (see: http://www.unitaid.org/#end). All Global Fund contributions were adjusted to represent 52% of the donor’s core contribution, reflecting the Fund’s reported grant approvals for HIV-related projects to date and includes funding for HIV/TB activities. Unitaid contributions were adjusted to represent 48% of the donor’s core contribution, reflecting Unitaid reported attribution for HIV-related projects.

Data obtained from UNAIDS, the Global Fund, and Unitaid were already adjusted to represent a USD equivalent based on date of receipts.

UNAIDS core contributions reflect amounts received in 2025. In 2024, the Netherlands provided two core contributions to UNAIDS; the first payment was provided for the 2024 contribution, while the second was a prepayment of the 2025 contribution. Global Fund and Unitaid contributions from all governments correspond to amounts received during the 2025 calendar year, regardless of which contributor’s fiscal year such disbursements pertain to.

In addition to contributions supporting the Global Fund’s and Unitaid’s core activities, some donor governments provided significant funding to these multilateral organizations for COVID-related efforts between 2020-2023. These COVID-specific contributions were not included in totals in this analysis. The U.S., for example, provided almost US$1.9 billion in such funding to the Global Fund during 2022. Other than contributions provided by governments to the Global Fund and Unitaid, un-earmarked general contributions to United Nations entities, most of which are membership contributions set by treaty or other formal agreement (e.g., the World Bank’s International Development Association or United Nations country membership assessments), are not identified as part of a donor government’s HIV assistance even if the multilateral organization in turn directs some of these funds to HIV. Rather, these would be considered as HIV funding provided by the multilateral organization, as in the case of the World Bank’s efforts, and are not considered for purposes of this report.

Appendix

Donor Government Funding for HIV (current USD in millions), 2024 & 2025 (Table)

Endnotes

  1. Donor government disbursements are a subset of overall international assistance for HIV in low-and-middle-income countries, which also includes funding provided by other multilateral institutions, UN agencies, and foundations. ↩︎
  2. UNAIDS estimates that US$17.6 billion was available for HIV from all sources (domestic resources, donor governments, multilaterals, and philanthropic organizations) in 2025, an 18% decline compared to 2024. In addition, while the amounts presented in this analysis include donor contributions to multilateral organizations, the UNAIDS estimate of total available resources for HIV includes the actual disbursements made by multilateral organizations in 2025 rather than the donor government contributions to these entities. ↩︎
  3. Between 2020-2023, some donor governments provided COVID-specific emergency contributions to the Global Fund and UNITAID in addition to their contributions for core activities. For the purposes of this report, these COVID-specific amounts have been excluded as they cannot be attributed to a specific area, such as HIV. ↩︎
  4. Donor government disbursements are a subset of overall international assistance for HIV in low-and-middle-income countries, which also includes funding provided by other multilateral institutions, UN agencies, and foundations. ↩︎
  5. UNAIDS, direct communication, July 2026. ↩︎
  6. UNAIDS estimates that US$17.6 billion was available for HIV from all sources (domestic resources, donor governments, multilaterals, and philanthropic organizations) in 2025, an 18% decline compared to 2024. In addition, while the amounts presented in this analysis include donor contributions to multilateral organizations, the UNAIDS estimate of total available resources for HIV includes the actual disbursements made by multilateral organizations in 2025 rather than the donor government contributions to these entities. ↩︎
  7. OECD, “A historic decline in foreign aid: Preliminary 2025 ODA data”, April 2026. ↩︎
  8. Between 2020-2023, some donor governments provided COVID-specific emergency contributions to the Global Fund and UNITAID in addition to their contributions for core activities. For the purposes of this report, these COVID-specific amounts have been excluded as they cannot be attributed to a specific area, such as HIV. ↩︎
  9. U.S. totals represent funding amounts provided through regular appropriations only. In 2021, the U.S. Congress appropriated additional emergency supplemental funding for bilateral HIV activities and for the Global Fund to address the impacts of the COVID-19 pandemic. These emergency supplemental funding amounts are not included in overall U.S. totals. ↩︎
  10. In 2025, France provided data revising prior year amounts to account for “set-aside” funding (adjusted for an HIV-share) that supports Global Fund related activities. While this funding is considered part of France’s pledge to the Global Fund, it is not counted by the Global Fund as a direct contribution and is instead included under bilateral totals in this analysis. Due to this update, amounts presented in this report will differ from prior reports. ↩︎
  11. Total HIV funding from the Netherlands in 2024 includes two core contributions to UNAIDS; the first payment was provided for the 2024 contribution, while the second was a prepayment of the 2025 contribution. ↩︎
  12. KFF, “The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)”, May 2026. ↩︎
  13. U.S. totals represent funding amounts provided through regular appropriations only. In 2021, the U.S. Congress appropriated additional emergency supplemental funding for bilateral HIV activities and for the Global Fund to address the impacts of the COVID-19 pandemic. These emergency supplemental funding amounts are not included in overall U.S. totals. ↩︎
  14. Between 2020-2023, some donor governments provided COVID-specific emergency contributions to the Global Fund and UNITAID in addition to their contributions for core activities. For the purposes of this report, these COVID-specific amounts have been excluded as they cannot be attributed to a specific area, such as HIV. ↩︎
  15. In 2025, 52% of the Global Fund’s disbursements and 48% of UNITAID’s disbursements were directed to HIV activities. These percentages were applied to the full donor government contributions to these multilateral organizations to calculate the “HIV-share” (see Methodology for additional details). ↩︎
  16. The U.S. has had a long-standing legislative requirement that total U.S. contributions to the Global Fund could not exceed 33% of all contributions (see “KFF – The U.S. & The Global Fund to Fight AIDS, Tuberculosis and Malaria”), which results in year-to-year fluctuations in U.S. payouts to the Global Fund depending on when other donors provide funds. However, this requirement technically expired in March when the authorization legislation ended (see “KFF - PEPFAR Reauthorization: Side-by-Side of Legislation Over Time”). ↩︎
  17. U.S. totals represent funding amounts provided through regular appropriations only. In 2021, the U.S. Congress appropriated additional emergency supplemental funding for bilateral HIV activities and for the Global Fund to address the impacts of the COVID-19 pandemic. These emergency supplemental funding amounts are not included in overall U.S. totals. ↩︎
  18. GDP estimates are from the International Monetary Fund’s (IMF) World Economic Outlook (WEO) Database (accessed July 2026). ↩︎

News Release

Donor Government Funding for HIV Drops by $2.1 Billion in 2025 Due to Declines in Funding from the United States, Marking Largest Annual Decrease Since Scale-up for the HIV Response Began

Published: Jul 27, 2026

Donor government funding to combat HIV in low- and middle-income countries fell by $2.1 billion in 2025, a 25% decrease from the previous year, according to a new report by KFF and the Joint United Nations Programme on HIV/AIDS (UNAIDS)

Total disbursements dropped to $6.2 billion in 2025, down from $8.3 billion in 2024, marking the largest single-year decline since donor funding scale-up began and the lowest funding level since 2007, the report finds.

The 2025 decrease was driven by a decline in U.S. disbursements following the administration’s substantial cuts in global health funding, programs, and personnel.  Despite this decline, the U.S. remains the largest donor to HIV in the world.

Excluding the U.S., HIV funding from all other donor governments, while steady in 2025, has declined by half since 2011 — from $3.2 billion in 2011 to $1.6 billion in 2025 — primarily due to reduced bilateral support. As a result, the U.S. share of total donor government funding for HIV has risen — from 59% in 2011 to 74% in 2025 — making available resources increasingly vulnerable to changes by the U.S., as was seen in 2025.

Looking ahead, donor government funding for HIV in 2026 and beyond is uncertain. The U.S. Congress has approved steady funding levels for HIV, but it remains unclear if this funding will be spent by the administration, which plans to cut global health funding in the coming years as part of its America First Global Health Strategy. In addition, after a significant decline in development assistance in 2025, the Organisation for Economic Co-operation and Development has projected further declines in 2026.

The donor government findings are part of a broader UNAIDS analysis of HIV financing from all sources, including domestic, multilateral and philanthropic funding, which found that overall international assistance for HIV declined by 18% between 2024 and 2025.

How Many Uninsured Are in the Coverage Gap and How Many Could be Eligible if All States Adopted the Medicaid Expansion?

Authors: Sammy Cervantes, Clea Bell, Jennifer Tolbert, and Anthony Damico
Published: Jul 27, 2026

Issue Brief

While millions of people have gained health coverage through Medicaid expansion under the Affordable Care Act (ACA) over the last decade, state decisions not to expand Medicaid continue to leave many without an affordable coverage option. In the 41 states including the District of Columbia that have adopted the expansion, adults with incomes up to 138% of the federal poverty level (FPL) are eligible for Medicaid. Medicaid expansion has led to significant coverage gains, particularly as more states adopted the expansion over the years. However, an estimated 1.2 million uninsured people in the ten states that have still not expanded remain ineligible for affordable coverage because they fall in the coverage gap—their incomes are too high for their states’ Medicaid program but too low to qualify for ACA Marketplace subsidies. Many adults in the coverage gap work or live with someone who works, are disproportionally people of color, and generally do not have dependent children.

The number of adults in the coverage gap is not expected to decline further as Medicaid changes in the 2025 reconciliation law make it less likely any state will newly adopt the expansion. The law eliminated the financial incentive included in the American Rescue Plan Act (ARPA) that was intended to encourage adoption of the expansion by non-expansion states and imposes new financial penalties on expansion states.

More broadly, policy changes in the 2025 reconciliation law and the expiration of enhanced Marketplace premium tax credits are expected to increase the number of uninsured people who do not fall in the coverage gap. Starting in January 2027, or earlier at state option, the 2025 reconciliation law requires all expansion states along with Georgia, Tennessee, and Wisconsin to condition Medicaid eligibility for individuals eligible through the expansion or waiver program on meeting work requirements. This new requirement is expected to result in significant coverage loss among expansion adults, with the Congressional Budget Office estimating that Medicaid work requirements will increase the number of uninsured individuals by 5.3 million over the next ten years. Yet these coverage losses will not increase the number of people in the coverage gap because adults who lose Medicaid because they do not meet or report work requirements continue to remain eligible for the program based on their income even if they lose Medicaid and become uninsured.

Using data from 2024, this brief estimates the number and characteristics of uninsured individuals in the ten non-expansion states who could gain coverage if Medicaid expansion were adopted.

How many people are in the coverage gap?

The coverage gap exists because not all states have adopted the ACA’s Medicaid expansion. The expansion extended Medicaid eligibility to adults ages 19-64 with incomes at or below 138% the federal poverty level (FPL), or $22,025 for an individual in 2026. Medicaid expansion covers both parents and adults without dependent children—who were previously not eligible for Medicaid. The “coverage gap” occurred because a 2012 Supreme Court ruling made Medicaid expansion optional for states, rather than the nationwide requirement Congress originally intended.

Status of State Action on the Medicaid Expansion Decision, as of May 2026 (Choropleth map)

Among the ten states that have yet to adopt Medicaid expansion, an estimated 1.2 million adults fall into the coverage gap because they earn too much to qualify for their state’s Medicaid program but not enough to access ACA Marketplace subsidies (Figure 2). Because the Medicaid expansion was intended to be mandatory for all states with Marketplace coverage available for individuals above the Medicaid limit, the minimum eligibility level for subsidies in the Marketplace was set at 100% FPL. When expanding Medicaid effectively became optional, poor adults living in states that decided not to expand were left without an affordable coverage option.



In states that have not expanded Medicaid, eligibility remains limited. The median income limit for parents is 40% FPL in these states, which is $10,928 per year for a family of three in 2026. Texas has the nation’s lowest eligibility threshold for parents at 15% FPL and bars Medicaid access for parents in a family of three earning more than $4,098, or $342 per month. With the exception of Wisconsin and Georgia, which offer coverage though a waiver, non-expansion states do not provide Medicaid coverage to adults under age 65 without dependent children, regardless of income, unless they qualify on the basis of disability (Figure 3). As a result, 78% of adults in the coverage gap are adults without dependent children.

Medicaid Income Eligibility Limits for Adults in States That Have Not Implemented the Medicaid Expansion (Split Bars)

States that have not expanded Medicaid have uninsured rates nearly twice as high as states that have expanded Medicaid (14.5% vs 8.0%). Adults who are uninsured have a harder time accessing care. In 2024, nearly four in ten adults (39%) without health insurance reported delaying or forgoing health care, including physical and mental health services and prescription medication, due to cost compared to 17% of adults with insurance. Uninsured individuals are also less likely than those with insurance to receive services to treat chronic conditions.

Why a Coverage Gap Does Not Exist in Georgia and Wisconsin

Although Georgia and Wisconsin have not adopted the Medicaid expansion, both states have expanded coverage to adults with income up to 100% FPL through an 1115 waiver, and therefore, a coverage gap does not exist in either state. In Georgia, the Georgia Pathways to Coverage waiver requires individuals to meet work requirements or qualify for an exemption in order to enroll. As a result, enrollment in the waiver program remains low.

Who is in the coverage gap and how many people could gain coverage if all states expanded Medicaid?

Most adults in the coverage gap work or live with someone who works, and they are disproportionately people of color. Six in ten adults in the coverage gap live in a family with a worker, and over four in ten are working themselves (Figure 4). Many are employed in low-wage jobs and often work for employers that do not offer affordable job-based coverage. Over half of workers in the coverage gap (58%) are employed in the service, retail, and construction industries, with common occupations including cashiers, servers, cooks, constructions labors, housekeepers, retails salespeople, and janitors. Because Medicaid eligibility levels for parents are so low in non-expansion states, even part-time work can make them ineligible. Additionally, Hispanic and Black adults make up over half (56%) of people in the coverage gap.

Characteristics of Adults 19-64
 in the Coverage Gap, 2024 (Grouped Bars)

If all remaining states adopted Medicaid expansion, approximately 2.4 million uninsured adults would become eligible for Medicaid. This includes 1.2 million in the coverage gap, who currently have no affordable coverage option, and 1.2 million with incomes between 100% and 138% of the FPL, who are eligible for but not enrolled in Marketplace coverage (Figure 5). For adults eligible for Marketplace coverage, Medicaid would offer an affordable alternative, generally with more comprehensive benefits and lower out-of-pocket costs. While some uninsured adults who are eligible for but not enrolled in Marketplace coverage could qualify for zero- or low-premium Marketplace coverage, the expiration of the temporary enhanced premium tax credits at the end of 2025 increased premiums for most Marketplace enrollees, and fewer adults are now eligible for zero-premium plans.

Uninsured Adults Ages 19-64 in Non-Expansion States Who Would Become Eligible for Medicaid if Their States Adopted the Medicaid Expansion, 2024 (Stacked column chart)
Uninsured Adults Ages 19-64 in Non-Expansion States Who Would Become Eligible for Medicaid if Their States Expanded, by Current Eligibility for Coverage, 2024 (Table)

How will changes in the 2025 reconciliation law affect the overall uninsured population?

Adults in the coverage gap represent a small share (4.5%) of the 26.7 million people ages 0-64 who were uninsured in 2024 (Figure 6). In the coming years, the number of adults in the coverage gap is unlikely to change substantially; however, the number of uninsured people overall is expected to increase. The Congressional Budget Office has estimated that Medicaid and Marketplace policy changes in the 2025 reconciliation law, most notably new Medicaid work requirements for adults enrolled in the Medicaid expansion, along with the expiration of the Marketplace enhanced premium tax credits, will increase the number of people who are uninsured by 14 million over the next decade. While some of the individuals who become uninsured will no longer be eligible for Medicaid or Marketplace coverage, others remain eligible but will lose coverage because they cannot meet work reporting requirements or are no longer able to afford their Marketplace premium.

Donut chart showing eligibility for health coverage among uninsured U.S. people ages 0–64 in 2024. Shares are divided among those eligible for tax credits (28.0%), Medicaid (24.2%), and those ineligible due to affordability or other factors, including 23.2% who lack affordable options, 19.4% ineligible due to immigration status, and 5.2% in the coverage gap.

Appendix Tables

Characteristics of Adults Ages 19-64 in the Coverage Gap, 2024 (Table)
Uninsured People Ages 19-64 Who Would Become Eligible if States Expanded Medicaid, by Race and Ethnicity, 2024 (Table)
Uninsured People Ages 19-64 Who Would Become Eligible if States Expanded Medicaid, by Age, 2024 (Table)
Uninsured People Ages 19-64 Who Would Become Eligible if States Expanded Medicaid, by Parental Status, 2024 (Table)
Uninsured People Ages 19-64 Who Would Be Eligible if States Expanded Medicaid, by Family Work Status, 2024 (Table)

Data and Methods

This analysis uses data from the 2024 American Community Survey (ACS). The ACS provides socioeconomic and demographic information for the United States population and specific subpopulations. Importantly, the ACS provides detailed data on families and households, which we use to determine income and household composition for ACA eligibility purposes.

Medicaid and Marketplaces have different rules about household composition and income for eligibility. The ACS questionnaire captures the relationship between each household resident and one household reference person, but not necessarily each individual to all others. Therefore, prior to estimating eligibility, we implement a series of logical rules based on each person’s relationship to that household reference person in order to estimate the person-to-person relationships of all individuals within a respondent household to one another. We then assess income eligibility for both Medicaid and Marketplace subsidies by grouping individuals into household insurance units (HIUs) and calculate HIU income using the rules for each program. For more detail on how we construct person-to-person relationships, aggregate Medicaid and Marketplace households, and then count income, see the detailed Technical Appendix A.

Undocumented immigrants are ineligible for federally-funded Medicaid and Marketplace coverage. Since ACS data do not directly indicate whether an immigrant is lawfully present, we draw on the methods underlying the 2013 analysis by the State Health Access Data Assistance Center (SHADAC) and the recommendations made by Van Hook et. Al.1,2 This approach uses the 2023 KFF/LA Times Survey of Immigrants to develop a model that predicts immigration status for each person in the sample.  We apply the model to ACS, controlling to state-level estimates of total undocumented population as well as the undocumented population in the labor force from the Pew Research Center. For more detail on the immigration imputation used in this analysis, see the Technical Appendix B.

Individuals in tax-filing units with access to an affordable offer of Employer-Sponsored Insurance (ESI) are still potentially MAGI-eligible for Medicaid coverage, but they are ineligible for advance premium tax credits in the Health Insurance Exchanges. Since ACS data do not designate policyholders of employment-based coverage nor indicate whether workers hold an offer of ESI, we developed a model that predicts both the policyholder and the offer of ESI based on the Current Population Survey (CPS). Additionally, for families with a Marketplace eligibility level below 250% FPL, we assume any reported worker offer does not meet affordability requirements and therefore does not disqualify the family from Tax Credit eligibility on the Exchanges. For more detail on the offer imputation used in this analysis, see the Technical Appendix C.

As of January 2014, Medicaid financial eligibility for most adults ages 19-64 is based on modified adjusted gross income (MAGI). To determine whether each individual is eligible for Medicaid, we use each state’s reported eligibility levels as of April 2025, updated to reflect 2026 Federal Poverty Levels. Some adults ages 19-64 with incomes above MAGI levels may be eligible for Medicaid through other pathways; however, we only assess eligibility through the MAGI pathway.3

An individual’s income is likely to fluctuate throughout the year, impacting his or her eligibility for Medicaid. Our estimates are based on annual income and thus represent a snapshot of the number of people in the coverage gap at a given point in time. Over the course of the year, a larger number of people are likely to move in and out of the coverage gap as their income fluctuates.

Starting with our estimates of ACA eligibility in 2017, we transferred our core modeling approach from relying on the Current Population Survey (CPS) Annual Social and Economic Supplement (ASEC) to the American Community Survey (ACS). ACS includes a 1% sample of the US population and allows for precise state-level estimates as well as longer trend analyses. Since our methodology excludes a small number of individuals whose poverty status could not be determined, our ACS-based population totals appear slightly below CPS-based totals and some ACS population totals published by the Census Bureau. This difference is in large part attributable to students who reside in college dormitories. Comparing the two survey designs, CPS counts more of these individuals in the household of their parent(s) than ACS does.

Code available at https://github.com/KFFData/CPS-ACS-Analytic-Code

Technical Appendices

KFF ACA Eligibility Analysis, Technical Appendix A: Household Construction

In KFF’s estimates of eligibility for ACA coverage, income eligibility for both Medicaid and Marketplace subsidies is assessed by grouping people into “health insurance units” (HIUs) and calculating HIU income according to Medicaid and Marketplace program rules. HIUs group people according to how they are counted for eligibility for health insurance, versus grouping people according to who they live with (e.g., “households”) or are related to (e.g., “families”). HIU construction is an important step in assessing income as a share of the federal poverty line (FPL) because it impacts whose income is counted (and thus the total income for the unit) and how many people share that income (and thus the corresponding FPL to use for comparison, since FPL varies by family size). Our HIUs are designed to match ACA eligibility rules for both Medicaid and Marketplaces. Below we describe how we construct HIUs for this analysis. The programming code, written using the statistical computing package R v.4.5.2, is available at https://github.com/KFFData/CPS-ACS-Analytic-Code for people interested in replicating this approach for their own analysis.

Person to Person Relationships

We construct spousal and parent-to-child person-to-person linkage variables within each household of the microdata. The American Community Survey (ACS) includes only the relationship of each person in a household to one central reference person. Using the household reference person's known relationships to all other individuals within each household, we iterate through every pair of individuals present in each household to determine probable person to person links for possible mother, father, and spousal pairs. Our approach to determining probable family interrelationship linkages closely follows the construction documented by IPUMS-USA with the notable exception of unmarried partner relationships.4 We intentionally diverge from IPUMS-USA because the presence of an unmarried partner relationship does not impact federal program eligibility. Among individuals designated as married with a spouse present in the household, our constructed spousal pointer matches the IPUMS SPLOC variable 99% of the time in the 2013 microdata. Our construction of mother and father pointers match the IPUMS MOMLOC, POPLOC, MOMLOC2, and POPLOC2 variables for more than 99% of all person-records.

Family Aggregation

Separate from person-to-person linkage variables, we assemble individual records into family units reproducing the Census Bureau's Family Poverty Ratio (POVPIP) variable. Although the Census Bureau does not include a unique family identifier on the ACS microdata, we approximate the groupings used to generate the ACS income-to-poverty ratio variable with the following steps:

  1. Both non-relatives of the household reference person (RELP of 11-17) and all individuals in non-family households (HHT of 4-7) are categorized as single-person families.
  2. Married couples and other family households without subfamilies (PSF of 0) are categorized into single-family households.
  3. Married couples and other family households with subfamilies (PSF of 1) are categorized based on their subfamily number (SFN).

This family identifier is used in estimating family-wide statistics, such as the percent of the uninsured Americans in a family below poverty or the count of Medicaid-enrollees with one or more workers in their family. This family aggregation matches the groupings used to determine the income-to-poverty ratio variable, and estimates of health insurance presented by family poverty categories align with Census Bureau publications based on the ACS.5 Since many family members obtain health coverage separately from one another (for example, an elderly parent cohabiting with their working-age child might hold Medicare coverage and Employer Sponsored Insurance, respectively), descriptive statistics focused on family attributes rely on this family identifier but Medicaid and Marketplace eligibility determinations do not.

Overview of KFF-HIUS 

We construct two different HIUs for everyone in the sample: a Medicaid HIU and a Marketplace HIU. We use two HIUs because the rules for counting families and income differ between the two programs. For example, in Medicaid, children with unmarried parents have both parents’ income counted toward their income, whereas under Marketplace rules, only the income of the parent who claims the child on his/her taxes counts. In another example, certain tax dependents (e.g., a parent) are treated differently for Medicaid eligibility than they are for Marketplace eligibility. To account for these rules, we developed an algorithm for sorting people into HIUs. We construct HIUs and HIU incomes separately for each person in a household and take into account the family relationships and income of the other people in the person’s household. People in the same household or in the same family may not have the same HIU composition or income for determining either Medicaid eligibility or eligibility for tax credits.

In simplest terms, the HIU algorithm sorts people into tax filing units. For all people in the data set, the algorithm assesses whether they are likely to be a tax filer themselves and, if so, who they are likely to claim or, if not, who is likely to claim them. It also captures whether someone is neither a tax filer nor claimed as a dependent by someone else. Importantly, the HIU construction considers all relationships for each person within the household. This step is particularly important in correctly classifying people in non-nuclear families (e.g., households with more than one generation, with unmarried partners, or with relatives outside the nuclear family such as an aunt or uncle), which may contain either one or multiple tax filing units.

In counting income for both Medicaid and Marketplace HIUs, we use modified adjusted gross income (MAGI), corresponding to the ACA rules. MAGI differs from total income in that some sources of income (e.g., cash assistance payments from TANF or SSI) do not count toward MAGI. We calculate HIU income as a share of poverty using the Health and Human Services Poverty Guidelines.6

For a small number of people, Medicaid HIU income as a share of poverty does not match Marketplace HIU income as a share of poverty due to the different rules between the programs. This analysis first calculates Medicaid HIU and classifies anyone who meets Medicaid eligibility into that category (including most individuals below 138% FPL in the Medicaid expansion states). We then calculate Marketplace HIU; anyone meeting subsidy eligibility is grouped into that category (above Medicaid and also above 100% FPL up to 400% FPL for most individuals). This approach follows the eligibility rules in the ACA, which specify that people are eligible for tax credits only if they are ineligible for Medicaid.

Steps in Calculating KFF-HIUS

Before we group people into HIUs, we first calculate annual MAGI for each respondent. We compare each person’s income to IRS filing requirements for being a tax filer7 and for being a qualifying relative claimed by someone else.8

We then group people into HIUs. We begin this process by grouping everyone within a household who is related into “cohabitating families.” Cohabitating families include all family relations; they also include unmarried cohabitating partners and relatives of each cohabitating partner.

Within each cohabitating family, we assess whether any individual is eligible to claim any other individual as a tax dependent. People are eligible to claim others as tax dependents if their income is above the IRS filing threshold for a head of household or, if married, for a married couple. People are eligible to be claimed by others if (a) they are a child (under age 19 or, for tax credits, 23 if a full-time student), and someone else in the cohabitating family has at least twice their income, or (b) they are below the limit to be a tax filer, have income below the qualifying relative limit, and someone else in the cohabitating family has at least twice their income. Within each cohabitating family, we assess who is likely to claim whom, using the assumptions that:

  • People who are claimed by others are more likely to be claimed by close relatives (e.g., a parent) than by others (e.g., a grandparent).
  • Married couples (who file) file jointly
  • If more than one person in a cohabitating family is eligible to claim others within that cohabitating family, the wealthiest person claims the eligible dependents.

Once we determine who within the cohabitating family is likely to claim each other, we know the HIU size and are able to apply income rules for the HIU. We apply Medicaid and Marketplace rules for whose income counts in calculating Medicaid HIUs and Marketplace HIUs, respectively.9 People who are filers but are not eligible to claim someone else or to be claimed by someone else are an HIU of 1. People who are not filers and are not claimed by filers have their HIU size and income counted according to Medicaid non-filer rules.10

Inflation Factors

In order to determine ACA eligibility during calendar year 2024, we compared tax filing unit income against the most current premiums available, for open enrollment 2026.11 We relied on the Bureau of Labor Statistics Employment Cost Index (ECI), Private Wages and Salaries to inflate the income of each HIU by approximately 7.0% to align 2024 incomes to 2026 premiums.12 Since most state Medicaid eligibility determinations through the MAGI pathway are calculated as a percent of HHS Poverty Guidelines for that year and not a fixed dollar amount, inflation was not necessary to assess the Medicaid eligibility of individuals.

After inflating 2024 tax filing unit incomes to match 2026 premiums, we similarly inflated 2024 IRS thresholds for both filing requirements13 and for qualifying relative tests14 by the same factor so that these thresholds aligned with the inflated income amounts.

Limitations

As with any analysis, there are some limitations to our approach due to the level of detail that we can obtain from available survey data. Key limitations to bear in mind include:

  • We currently are not able to appropriately group anyone who lives outside the household with a household that claims them as a tax dependent. For example, we are not able to connect students living away from home or children with a non-custodial parent with the people who may be claiming them (and whose income should count to their HIU). We are also not able to determine married people who file separately.
  • To group people into tax filing units, we have to make assumptions about how people are likely to file their taxes. We assume that tax filers claim qualifying relatives they are able to claim. We make this assumption based on the fact that Medicaid and Marketplace eligibility rules are determined not by who is actually claimed on the tax return but by who is allowed to be claimed. However, people may sort themselves into different tax filing units than we estimate.

KFF ACA Eligibility Analysis, Technical Appendix B: Immigration Status Imputation

To impute documentation status, we draw on the methods underlying the 2013 analysis by the State Health Access Data Assistance Center (SHADAC) and the recommendations made by Van Hook et. al..15,16 This approach uses the 2023 KFF/LA Times Survey of Immigrants to develop a model that predicts immigration status for each person in the sample.17 We apply the model to a second data source, controlling to state-level estimates of total undocumented population as well as the undocumented population in the labor force from the Pew Research Center.18 Below we describe how we developed the regression model and applied it to the American Community Survey (ACS). We also describe how the model may be applied to other data sets. The programming code, written using the statistical computing package R v.4.5.2, is available at https://github.com/KFFData/CPS-ACS-Analytic-Code for people interested in replicating this approach for their own analysis.

Data Sources

We used the 2023 KFF/LA Times Survey of Immigrants data to build the regression model. The 2023 Survey of Immigrants dataset contains questions on citizenship and legal status at the person level. The KFF/LA Time Survey of Immigrants19 is a probability-based survey exploring the immigrant experience in the U.S. and draws on three different sampling frames including an address-based sample (ABS), a random digit dial (RDD) sample of pre-paid cell phone numbers, and callbacks to an RDD sample in which the individual did not speak English or Spanish. The survey includes interviews with 3,358 immigrant adults and was offered in ten different languages.

The regression model is designed to be applied to other datasets in order to impute legal immigration status in surveys that do not ask about migration status. The code mentioned above includes programming to apply the model to either the Survey of Income and Program Participation (SIPP) Core files, ACS, or the Current Population Survey (CPS). Because the SIPP Core file contains different survey questions and variable specifications from the ACS and CPS, we create unique regression models to apply the model to each dataset. For the analysis underlying this brief and other KFF estimates of eligibility for ACA coverage, we apply the regression model to the 2013 ACS and then each subsequent year of the ACS.

Due to underreporting of legal immigration status in survey datasets, in imputing immigration status we control to state and national-level estimates of the total undocumented population and also the undocumented population in the labor force from the Pew Research Center. Pew reports these estimates for all states and the District of Columbia.20

Construction of Regression Model

We use the 2023 Survey of Immigrants to create a binomial, dependent variable that identifies a respondent as a potential unauthorized immigrant. The dependent variable is constructed based on the following factors:

  1. Respondent was not a United States (US) citizen,
  2. Respondent did not have permanent resident status or a valid work or student visa, , and
  3. Respondent does not have other indicators that imply legal status.21

We use the following independent variables to predict unauthorized immigrant status:

  1. Year of US entry,
  2. Job industry classification,
  3. State of residence,
  4. Household Income,
  5. Ownership or rental of residence,
  6. Number of occupants in the household (< or >= six occupants),
  7. Whether all household occupants are related,
  8. Health insurance coverage status,
  9. Country of birth,
  10. Sex, and
  11. Ethnicity.

The regression model was sub-populated to remove respondents who could not be considered unauthorized. People who could not be considered unauthorized include people who are US citizens or have other indicators that imply legal status.

Imputing Unauthorized Immigrants in Other Datasets

We use the Pew estimates as targets for the total number of unauthorized immigrants that the imputation generates. We first apply this strategy to the 2013 ACS, which contains health insurance information prior to the ACA's coverage expansions. We stratify the targets by state and the District of Columbia and by participation in the labor force. We impute immigration status within each of these 102 strata.22

To generate the imputed immigration status variable, we first calculated the probability that each person in the dataset was unauthorized based on the 2023 Survey of Immigrants regression model. Next, we isolated the dataset to each individual stratum described above. Within each stratum, we sampled the data using the probability of being unauthorized for each person. After sampling, we summed the person weights until reaching the Pew population estimate for each stratum. The records that fell within the Pew population estimate were considered to be unauthorized immigrants. We repeated the process of sampling using the probability of being unauthorized and subsequently summing the person weights to reach Pew targets five times, creating five different unauthorized variables per record. These five imputed authorization status variables were then incorporated into a standard multiple imputation algorithm, closely matching the imputed variable analysis techniques used by the Centers for Disease Control and Prevention for the National Health Interview Survey.23

To easily apply the regression model to other data sets, we created a function that applies this approach to a chosen data set. The function first loads the dataset of choice, then standardizes the data to match the independent variables from the 2023 Survey of Immigrants regression model, and finally applies the multiple imputation to generate a variable for legal immigration status.

KFF ACA Eligibility Analysis, Technical Appendix C: Imputation of Offer of Employer-Sponsored Insurance

An integral part of determining ACA eligibility is assessing whether workers without employer-sponsored insurance (ESI) hold an offer through their workplace that they decline to take up. In most cases, an affordable offer of ESI disqualifies members of the tax filing unit of the worker from receiving subsidized coverage on the ACA Health Insurance Marketplace. The American Community Survey (ACS) does not ask about employer offers of ESI; however, the Current Population Survey Annual Social and Economic Supplement (CPS-ASEC) includes questions about whether each worker received an offer of ESI from his or her employer at the time of interview. We use the CPS-ASEC offer of ESI variable to inform a regression-based multiple imputation of whether each tax filing unit constructed in the ACS had at least one offer at work, and also assess affordability for the employee and, separately, for any potential dependents within the unit. Since the health insurance coverage variables available in the CPS-ASEC 2025 capture sources of coverage at any point during calendar year 2024 (versus at the time of survey, as with the offer rate variable), a subset of sampled individuals had a change in their employer-based coverage status across the two distinct time periods.24 Therefore, among workers who potentially experienced a shift in offer status across the two time periods, we recoded or imputed offer rates in 2024 using the offer status in 2025. After constructing this revised offer variable for workers in CPS, we aggregated the results at the tax filing unit level to create a prediction model to apply to the ACS. Below we describe these recodes and imputation. The programming code, written using the statistical computing package R v.4.5.2, is available at https://github.com/KFFData/CPS-ACS-Analytic-Code for people interested in replicating this approach for their own analysis.

Recoding and Imputing Offer Rate Data in the CPS

As a first step in our analysis, we divided CPS-ASEC survey respondents into five distinct groups:

  1. All individuals who did not work during 2024 and also did not hold an offer of ESI in 2025 were assumed not to have an offer in 2024.
  2. All individuals who reported being an ESI policyholder (that is, anyone reporting having taken-up their offer of ESI) during 2023 and also reported holding an offer of ESI during early 2025 were assumed to have an offer in 2024.
  3. All workers in 2024 who held their own ESI policies during 2023 but then reported not holding an offer during 2025 were re-coded as holding an offer of ESI in 2024.
  4. All non-workers during 2024 who reported holding an offer during 2024 were re-coded as not holding an offer of ESI in 2024.
  5. Some workers during 2024 who did not report being ESI policyholders but did report holding an offer of ESI during early 2025 were imputed to not have an offer of ESI during 2024.

For many groups, including those in groups (1) and (2) listed above, the offer status did not change across the two time periods. In contrast, we recoded offer status for people in groups (3) and (4): every non-offered worker in group (3), which includes people who held ESI policies in their own name in 2024, were considered to have an offer of ESI in 2024, and offered workers in group (4), which includes people who did not work themselves in 2024, were considered to not have their offer of ESI in 2024. Last, we implemented a probability-based random sample imputation of offers of ESI for people in group (5), described in more detail below. Only a subset of the group was re-coded from holding an offer in 2025 to not holding an offer in 2024.The number of workers selected from this population was equal to the population size of (3) subtracted by the population size of (4), thereby assuming an unchanging offer rate for the total worker population across the period.

Imputing Offer Rates for CPS Respondents with Ambiguous Offer Rate Status

The CPS-ASEC worker-level regression model was designed to be applied to a single dataset where ESI offer status is known at one point in time but not another. The code mentioned above includes programming to apply the model to the Current Population Survey (CPS-ASEC) (for years 2014 on). For the analysis underlying KFF’s current estimates of ACA eligibility, we apply the regression model to workers in the 2025 CPS-ASEC.

  • We use the 2025 point-in-time worker offer variable provided by the US Census Bureau25 to create a binomial, dependent variable that identifies a respondent as a recipient of an offer of employer-sponsored insurance at his or her workplace in early 2025. The dependent variable was constructed at the worker-level based on individuals not holding their own ESI policy at time of interview and also reporting an ESI offer or eligibility to be covered that was then voluntarily declined.

We use the following independent variables to predict offer status in 2024 among workers not covered by their own ESI during both 2024 and early 2025 but potentially holding an offer of ESI in 2024:

  • Any public coverage,
  • Any nongroup coverage,
  • Worker earnings among all jobs,
  • Full-time versus part-time status,
  • Age of worker,
  • Work within the construction industry.

The regression model was sub-populated to remove respondents already covered by their own ESI and also to remove non-workers. Since this imputation does not account for the affordability of the offer or whether it meets the minimum value test, we included an assumption that workers in tax filing units with a MAGI below 250% FPL do not hold affordable offers of ESI and therefore might be eligible to purchase subsidized coverage on the Exchanges.26

As mentioned above, we assume an unchanging offer rate for the total worker population across the two time periods. We determined the needed size of the population to impute by subtracting the population of (4) from the population of (3) to ensure an equivalent number of offers were gained and lost. This left only workers who reported holding an offer of ESI during early 2025, since (3) represented a larger count of workers than (4). We then calculated the probability that each worker in the dataset was offered ESI during calendar year 2024 based on our 2025 CPS-ASEC regression model. Next, we selected workers within the potential population (5) using the sampling probabilities resultant from our model.

Construction and Application of ACS Regression Model

For the analysis underlying KFF estimates of ACA eligibility, we construct a prediction model of having an offer of ESI using the 2025 CPS-ASEC and then apply this regression to tax filing units in the 2024 ACS to estimate who has an ESI offer in ACS.

We aggregate the worker offer variables constructed the 2025 CPS-ASEC as described above to create a binomial, dependent variable that identifies each tax filing unit as either holding or not holding an affordable offer of employer-sponsored insurance.

We use the following independent variables to predict offer status among tax filing units:

  • Any senior citizen in the household,
  • Oldest member of the tax-filing unit,
  • Any member of the tax-filing unit has employer-sponsored insurance coverage,
  • Any member of the tax-filing unit has nongroup coverage,
  • Any uninsured individuals in the tax filing unit,
  • Share of adults working full-time and part-time, and
  • Highest worker earnings.

Since the imputation of documentation status (discussed in Technical Appendix B) required a multiply-imputed approach, this secondary imputation and subsequent worker sampling was only conducted once per implicate, keeping the number of ACS implicates to five.

Endnotes

  1. State Health Access Data Assistance Center. 2013. “State Estimates of the Low-income Uninsured Not Eligible for the ACA Medicaid Expansion.” Issue Brief #35. Minneapolis, MN: University of Minnesota. Available at: http://www.rwjf.org/content/dam/farm/reports/issue_briefs/2013/rwjf404825. ↩︎
  2. Van Hook, J., Bachmeier, J., Coffman, D., and Harel, O. 2015. “Can We Spin Straw into Gold? An Evaluation of Immigrant Legal Status Imputation Approaches” Demography. 52(1):329-54. ↩︎
  3. Non-MAGI pathways for nonelderly adults include disability-related pathways, such as SSI beneficiary; Qualified Severely Impaired Individuals; Working Disabled; and Medically Needy. We are unable to assess disability status in the ACS sufficiently to model eligibility under these pathways. However, previous research indicates high current participation rates among individuals with disabilities (largely due to the automatic link between SSI and Medicaid in most states, see Kenney GM, V Lynch, J Haley, and M Huntress. “Variation in Medicaid Eligibility and Participation among Adults: Implications for the Affordable Care Act.” Inquiry. 49:231-53 (Fall 2012)), indicating that there may be a small number of eligible uninsured individuals in this group. Further, many of these pathways (with the exception of SSI, which automatically links an individual to Medicaid in most states) are optional for states, and eligibility in states not implementing the ACA expansion is limited. ↩︎
  4. Steven Ruggles, Sarah Flood, Ronald Goeken, Josiah Grover, Erin Meyer, Jose Pacas, and Matthew Sobek. IPUMS USA: Version 8.0 [dataset]. Minneapolis, MN: IPUMS, 2018. https://doi.org/10.18128/D010.V8.0 For a detailed description of how IPUMS constructs family interrelationships variables, see https://usa.ipums.org/usa/chapter5/chapter5.shtml ↩︎
  5. According to the Public Use Microdata Sample (PUMS) documentation, "Estimates generated with PUMS microdata will be slightly different from the pretabulated estimates for the same characteristics published on data.census.gov. These differences are due to the fact that the PUMS files include only about two-thirds of the cases that were used to produce estimates on data.census.gov, as well as additional PUMS edits." ↩︎
  6. Medicaid eligibility in 2026 is based on 2026 poverty guidelines, available at: U.S. Department of Health and Human Services, Office of The Assistant Secretary for Planning and Evaluation, Poverty Guidelines. https://aspe.hhs.gov/topics/poverty-economic-mobility/poverty-guidelines. Tax credit eligibility in 2026 is based on 2025 poverty guidelines, available at: U.S. Department of Health and Human Services, Office of The Assistant Secretary for Planning and Evaluation, 2025 Poverty Guidelines https://aspe.hhs.gov/topics/poverty-economic-mobility/poverty-guidelines/prior-hhs-poverty-guidelines-federal-register-references↩︎
  7. See Internal Revenue Service, Publication 501, Table 1.2024: Filing Requirements Chart for Most Taxpayers. Available at: https://www.irs.gov/pub/irs-prior/p501--2024.pdf. ↩︎
  8. See Internal Revenue Service, Publication 501, Qualifying Relative. Available at: https://www.irs.gov/pub/irs-prior/p501--2024.pdf. ↩︎
  9. A detailed explanation of Medicaid and Marketplace income counting rules can be found in Center on Budget and Policy Priorities webinar available at: http://www.healthreformbeyondthebasics.org/wp-content/uploads/2013/08/Income-Definitions-Webinar-Aug-28.pdf. ↩︎
  10. A detailed explanation of Medicaid and Marketplace HIU size calculations can be found in the Center on Budget and Policy Priorities webinar available at http://www.healthreformbeyondthebasics.org/wp-content/uploads/2013/08/Household-Definitions-Webinar-7Aug13.pdf. ↩︎
  11. This is the same underlying data as the 2026 Health Insurance Marketplace Calculator. Available at: https://www.kff.org/interactive/subsidy-calculator/. ↩︎
  12. See Congressional Budget Office, Economic Projections. Available at: https://www.cbo.gov/system/files/2025-09/51135-2025-09-Economic-Projections.xlsx. ↩︎
  13. See Internal Revenue Service, Publication 501, Table 1.2024: Filing Requirements Chart for Most Taxpayers. Available at: https://www.irs.gov/pub/irs-prior/p501--2024.pdf. ↩︎
  14. See Internal Revenue Service, Publication 501, Qualifying Relative. Available at: https://www.irs.gov/pub/irs-prior/p501--2024.pdf. ↩︎
  15. State Health Access Data Assistance Center. 2013. “State Estimates of the Low-income Uninsured Not Eligible for the ACA Medicaid Expansion.” Issue Brief #35. Minneapolis, MN: University of Minnesota. Available at: http://www.rwjf.org/content/dam/farm/reports/issue_briefs/2013/rwjf404825. ↩︎
  16. Van Hook, J., Bachmeier, J., Coffman, D., and Harel, O. 2015. “Can We Spin Straw into Gold? An Evaluation of Immigrant Legal Status Imputation Approaches” Demography. 52(1):329-54. ↩︎
  17. This data source is a change from previous KFF analyses, which used microdata from the 2008 Panel of the Survey of Income and Program Participation (SIPP) ↩︎
  18. This data source is a change from previous KFF analyses, which used estimates from the Department of Homeland Security. ↩︎
  19. More information about the survey methods is available at https://www.kff.org/report-section/understanding-the-u-s-immigrant-experience-the-2023-kff-la-times-survey-of-immigrants-methodology/ ↩︎
  20. Pew updates these estimates periodically. We use the most recent estimates available at the time of our analysis, and in some cases incorporate estimates received from correspondence with researchers at Pew prior to their publication - however we do not release these numbers ourselves. We draw on Pew directly for all published data and interpolate years missing from their trend. Our analysis uses the year applicable to the year for the data sets to which we apply the regression model. The most recent estimates as of the time of our analysis were: J Passel, J Krogstad. U.S. Unauthorized Immigrant Population Reached a Record 14 Million in 2023. (Pew Research Center), August 2025. Available at: https://www.pewresearch.org/race-and-ethnicity/2025/08/21/u-s-unauthorized-immigrant-population-reached-a-record-14-million-in-2023/. ↩︎
  21. Indicators that imply legal status include: (i) respondent entered the US prior to 2000, (ii) respondent is enrolled in Medicare or military health insurance, or (iii) respondent reports Medicaid coverage but resides in a state that does not offer coverage to the undocumented population beyond CHIP’s From-Conception-to-End-of-Pregnancy (FCEP) option. ↩︎
  22. For more information, see SHADAC 2013, footnote 1. The table created for this function contains estimates of the undocumented across 2013, 2023, and 2024. ↩︎
  23. For more detail, see documentation available at: National Health Interview Survey. 2024 Imputed income technical document. Available at: https://www.cdc.gov/nchs/nhis/documentation/2024-nhis.html. ↩︎
  24. For example, anyone who did not work during 2024 who then held an offer of ESI in early 2025 would appear incongruous in our CPS-based eligibility model.  In the other direction, workers covered by health insurance through their own employer in 2024 who lost their offer of ESI during the early months of 2025 (perhaps due to a job change) would also appear incongruous due to the discrepancy across the two time periods. ↩︎
  25. Available at: https://www.census.gov/data/datasets/time-series/demo/health-insurance/cps-asec-research-files.html. For more detail about these microdata, see: J. Abramowitz, B. O'Hara.  New Estimates of Offer and Take-up of Employer-Sponsored Insurance (US Census Bureau), 2016.  Available at: https://www.census.gov/library/working-papers/2016/demo/Abramowitz-2016.html. ↩︎
  26. For an explanation of affordability, see: KFF. Employer Responsibility Under the Affordable Care Act. February 2024. Available at: https://www.kff.org/infographic/employer-responsibility-under-the-affordable-care-act/. ↩︎

How State Policies Shape Access to Abortion Coverage

Editorial note: Updated July 24, 2026 with new updates for Pennsylvania.

State and federal efforts to limit abortion coverage began soon after the 1973 Supreme Court’s Roe v Wade decision. In 1977, the Hyde Amendment banned federal funding for abortion, with exceptions for pregnancies that endanger the life of the woman, or result from rape or incest. Some states use their own funds to cover other medically necessary abortions for their Medicaid enrollees or have been compelled to do so by the courts. The passage of the ACA in 2010 led to renewed legislative efforts to limit abortion coverage, this time in private insurance plans. The ACA maintains the Hyde Amendment’s limits, and permits states to ban abortion coverage from Marketplace plans. Since 2010, many states have enacted private plan restrictions and also banned abortion coverage from Marketplace plans, some of which are more restrictive than the Hyde limitations. A handful of states, however, have enacted laws that require private plans to cover abortion and state funds to cover abortions for Medicaid enrollees.

The interactive map below shows the increase in states with laws restricting abortion coverage for Medicaid and private insurance enrollees in 2010 compared to the present.

State Policies on Abortion Coverage for Medicaid, Private Insurance, and ACA Exchange Plan Enrollees – 2026 (Choropleth map)

On June 24, 2022, the Supreme Court overturned Roe v. Wade, eliminating the federal constitutional standard that had protected the right to abortion. States can now set their own policies to ban or protect abortion. As of January 6, 2026, 13 states have banned abortion (Alabama, Arkansas, Idaho, Indiana, Kentucky, Louisiana, North Dakota, Mississippi, Oklahoma, South Dakota, Tennessee, Texas, and West Virginia). For more details about legal status of abortion in states, please visit our Abortion in the United States Dashboard.

Medicaid Coverage Limitations (29 states & DC) - State limits Medicaid coverage of abortion to the Hyde Amendment restrictions (only allowed in the cases of rape, incest or life endangerment).

Private Insurance Coverage Limitations (10 states) - State has a law that prohibits coverage of abortions from being included in private insurance policies sold in the state (with certain exceptions). Private insurance includes individual, small group, and large group. Some states may allow abortion coverage to be purchased as a rider.

State Marketplace Coverage Limitations (25 states) - State has a law that prohibits plans sold on state Marketplaces from covering abortion (with certain exceptions).

No Coverage Limitations (6 states) - State does not limit coverage of abortion in private insurance or the state Marketplace and the state does not ban the use of state funds (non-federal) to pay for abortion for Medicaid enrollees in circumstances outside of those allowed by the Hyde Amendment.

Requires Abortion Coverage in Private and ACA Marketplace Plans and for Medicaid Enrollees (13 states) - State requires all fully-insured group plans and individual plans to include abortion coverage and state funds to cover abortion for Medicaid enrollees. Ten of these states require no cost-sharing for abortion—Illinois and Minnesota allow cost sharing if there is cost-sharing for similar services in the plan and Delaware prohibits cost-sharing for abortions up to $750.

Medicaid Work Requirements: Federal Outreach Requirements and State Plans

Published: Jul 24, 2026

The 2025 reconciliation law requires 44 states to condition Medicaid eligibility for adults in the Affordable Care Act (ACA) Medicaid expansion group and certain enrollees in 1115 waiver programs, including in non-expansion states (Georgia, Tennessee, and Wisconsin), on meeting work requirements starting January 1, 2027. Implementing work requirements will require complex changes to eligibility and enrollment systems and processes. States will also need to conduct targeted outreach and education to enrollees and potential applicants as well as broader outreach to providers and managed care plans to inform them of the changes. On June 1, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a long-anticipated interim final rule that will guide state implementation of Medicaid work requirements, including outreach efforts.

As states begin the process of implementing new Medicaid work requirements, they may draw on lessons from their experience with “Medicaid unwinding.” During the unwinding, states conducted eligibility redeterminations for everyone on the program and disenrolled those who were no longer eligible or who did not complete the renewal process. KFF interviews with state officials, managed care plans, primary care associations, and advocacy organizations involved with the Medicaid unwinding in 2023, as well as interviews from the 23rd annual budget survey of Medicaid officials, identified successful outreach and communication strategies and partnerships to reach and educate enrollees about changes to the program.

The new requirements are complex and the implementation timelines are tight, so effective outreach, notices and communication will be challenging. These challenges were exacerbated by unexpected changes in the final rule that are likely to result in necessary changes to notices and other outreach materials. Because work requirements represent a change to eligibility requirements that apply to only some Medicaid enrollees, there will be unique challenges developing messages and strategies to explain the new requirements to those who need to meet the requirements while making clear who is not affected. In addition, states face several other challenges in conducting outreach, many of which reflect long-standing issues in Medicaid eligibility outreach processes. Describing eligibility processes in notices and outreach materials with clear, accessible language has been difficult for states. States have limited resources and workforce capacity for developing outreach materials. Call centers, an important resource to contact state Medicaid agencies with eligibility concerns, operate limited hours that may be inaccessible for many individuals. States must comply with federal rules on what work can be done through managed care organizations (MCOs).

This brief describes the outreach requirements in the law and rule, and highlights examples of outreach efforts states have shared during recent Medicaid Advisory Committee (MAC) meetings or on state websites. Some examples include outreach relating to other eligibility changes from the 2025 reconciliation law. State examples do not represent a comprehensive list of states adopting any strategy mentioned. This brief uses “work requirements” to describe the upcoming changes, though states sometimes use other language including “community engagement requirements” or “activity requirements” in their materials. Most examples were shared prior to the release of the interim final rule and may not fully reflect the rule’s requirements.

Federal Outreach and Notice Requirements

States are required to send targeted outreach notices to enrollees who may be subject to work requirements informing them of new work requirements. While the reconciliation law only requires notices to be sent to enrollees who are subject to work requirements, not including enrollees who are excluded from the requirements, (such as those who are medically frail or who are parents of children under age 14), the rule requires states to send notices to all expansion adults and all enrollees in 1115 waiver programs that are subject to the requirements. The Centers for Medicare & Medicaid Services (CMS) notes that sending notices to all expansion and all enrollees in applicable waiver programs is necessary because states will not have enough information to determine all individuals who should be excluded from the requirements and because enrollees may experience changes in circumstances that could affect whether they must comply with or are exempt from the work requirements between the time notices are sent and the requirements are implemented.

The law requires that notices explain who is subject to work requirements, how to comply with the requirements, and the consequences of noncompliance. The rule notes that because states must send notices to all expansion and applicable waiver enrollees, they will need to explain in clear language in the notice who qualifies for an exception or is a specified excluded individual and, therefore, does not need to comply with the requirements. The rule also requires that notices indicate how many months the state will look back at renewal to verify compliance. The law states that notices must be shared with enrollees in at least two different modalities including regular mail (or, if elected by the individual, in an electronic format) and in one or more additional modalities (including phone, text, online account). The rule reflects existing federal regulations that require notices to use plain language and be accessible for individuals with limited English proficiency (LEP) and individuals with disabilities.

The law requires notices to be sent three months prior to the first lookback month, meaning most states must send outreach notices in September. For states implementing work requirements on January 1, 2027 and that look back one month at application, the first lookback month is December 2026; therefore, outreach notices must be sent in September. For states that look back three months at application, outreach notices must be sent in July. In a recent KFF survey (fielded January-March 2026), most states that had made a decision (36) plan to look back one month to verify compliance at application. Two states (Idaho and Indiana) reported plans to look back three months at application, requiring them to begin sending notices in July. The rule requires states to send outreach notices to new enrollees who enroll after the initial outreach notices are sent and before the states implements the requirements.

States may send outreach notices along with an eligibility determination notice or other communications. States can utilize Medicaid MCOs to send outreach notices and must direct MCOs on which individuals must receive the notice, the frequency of when notices must be sent, and the required content of the notice.

After the initial outreach notice, states must send notices on a periodic basis. The rule lists several situations when states must send additional notices including, following application, renewal, and a change in circumstance; when a hardship exception is adopted, terminated, or expires; if the enrollees is no longer shown to be exempt from complying with work requirements; and upon request by CMS if monitoring data on work requirements indicates a problem.

Figure 1

In addition to sending targeted outreach notices, federal rules require states to post information about work requirements on their websites. The rule clarifies that the existing requirement for states to make program information available on their websites includes providing information about work requirements. While no other broad outreach is required, the rule encourages states to engage in additional outreach and education to raise community awareness of the new requirements.

State Outreach Plans

Beyond federal requirements, states are adopting a wide range of additional outreach strategies (Figure 2). Common strategies include additional direct enrollee communications through letters or other modalities, broad outreach through mass media and community events, and outreach to educate and engage providers, health plans, and community based organizations.

Figure 2

Direct Enrollee Communication

States are deliberating and making decisions about enrollee notices related to work requirements. Some states have shared draft notices with MAC members and other partners to get feedback on clarity and whether the language is clear and at an appropriate reading level. Nebraska and Montana, which have already implemented work requirements, sent notices to enrollees before the rule was published.

  • Nebraska’s notice was sent in December 2025. The three-page notice shared information about Medicaid expansion, what work requirements are, when and how Nebraska Medicaid will check work requirement compliance, consequences of noncompliance, and exemptions. There is also information about the importance of reporting changes that may affect eligibility, job seeking assistance, and the Medicaid agency’s contact information. The notice does not inform enrollees of how many months the state will look back at to verify compliance, which is required under the final rule.
  • Montana’s state plan amendment (SPA) to implement work requirements early required the state to send notices to affected enrollees in April 2026 and specified the content of the notices, which was similar to that of the final rule. Both the final rule and Montana’s draft SPA require that notices are sent to affected enrollees and explain work requirements, how to comply with the requirements, and the consequences of noncompliance. Unlike the rule, the Montana SPA does not explicitly require information about acceptable activities, exemptions, who is affected, and look-back periods.
  • Nevada used MAC meeting time to solicit feedback on a draft notice. To keep messaging inclusive of the acceptable activities for compliance, members discussed different language that could be used in place of “work requirements” like “work and volunteer requirements” or “work, school, and volunteer requirements.”
  • Pennsylvania is considering color coding notices to identify enrollees who will be newly subject to work requirements. Pennsylvania already utilizes color coding by sending renewal forms in pink envelopes. The suggestion to use color coded notices would indicate to enrollment assistors and navigators whether the enrollee they are assisting needs to meet the new requirements.

Additional Direct Enrollee Communication

Beyond required outreach notices, states also plan to send additional direct outreach to enrollees notifying them of upcoming work requirements implementation. Some communications are tailored to enrollees who will be subject to work requirements, and some will be broadly sent to all enrollees. These communications are not subject to the requirements on formal outreach notices that were outlined in the final rule.

  • Montana sent a letter to all Medicaid enrollees in March with basic information about who may be subject to work requirements. The letter directed enrollees to the state’s website on work requirements and assured enrollees that they do not need to act yet, but would receive an additional letter with more information on how to comply if they were subject to work requirements. Montana also began adding messaging on work requirements to renewal reminder emails and text messages in the spring.
  • In Vermont’s first MAC meeting following release of the rule, members reviewed a draft postcard that will be sent to all households with Medicaid enrollees. MAC members discussed how overly broad descriptions of affected enrollees may lead exempt expansion enrollees and enrollees eligible through other pathways to mistakenly assume that the work requirements apply to them.
  • New Jersey sent letters describing all eligibility changes between April and June. From July to September, New Jersey will send additional follow-up letters specifically about work requirements

Call Centers

States are required to offer telephone assistance with Medicaid applications and renewals. For work requirements, call centers can be utilized for enrollees to ask questions about work requirements and submit information about changes in their circumstances. Currently, several state websites on work requirements share call center information. As states increase outreach with notices and other materials that list call center information, more individuals will be prompted to contact call centers. Call center staffing may need to increase to accommodate the higher volume of calls. In addition to increasing staff capacity, staff may need additional training on how to help individuals navigate work requirements and have appropriate resources to share with callers who may be subject to work requirements. Call centers typically operate Mondays through Fridays during business hours, which may limit access for individuals who cannot call during those hours.

  • Nebraska and Delaware’s websites encourage enrollees to report changes in circumstances to the state’s existing Medicaid eligibility call center, with both call centers operating during business hours.
  • Arkansas plans to conduct proactive calls to notify enrollees who will need to comply. The state will use the calls to inform enrollees on the changes and remind enrollees to report changes in circumstances.

Enrollee Websites and Screening Tools

Most states have launched websites to centralize information on the eligibility changes required by the reconciliation law, including work requirements, that provide an overview of the new requirements as well as timelines, FAQs, and links to community resources. The information on state websites specific to work requirements describes, in general terms, which Medicaid enrollees may be subject to work requirements and who qualifies as an excluded individual and will be exempt from the requirements. Some websites have dedicated pages on work requirements that include more detailed information. Websites mostly provide information for enrollees and new or potential applicants, but some also provide information tailored to providers or health plans. Most websites encourage enrollees to check their mail often and keep contact information up to date, along with information on how to report changes to the state Medicaid agency. Some websites have links to sign up to the state Medicaid agency’s email subscription list.

  • Nebraska’s website features a 10-minute-long YouTube video overview of work requirements. While the video offers important information about work requirements in a format that some people may find more accessible, it contains some technical language that may be hard for enrollees and applicants to understand. Nebraska’s website shares other resources including links to community service and job seeking opportunities.
  • Montana has a website showing the intended goals of the work requirements, key changes, and flyers on work requirements and exemptions/temporary exemptions. The website states that enrollees will receive timely notices and shares information on appeals.

Some websites currently include fairly limited information on work requirements, often as part of information on broader Medicaid changes in the law while others provide more details that may help enrollees and potential applicants navigate work requirements.

  • Missouri has an “Implementation Hub” website that provides high-level summary information on all of the Medicaid and SNAP changes in the law.
  • In contrast, Colorado and Idaho’s websites provide more detailed information on how to comply with the new work requirements, noting that earning at least $580 from paid work verifies compliance, who will be exempt, and when the requirements will take effect.

Since not all Medicaid enrollees will be affected by work requirements, some states are launching screening tools for enrollees to check if they will need to comply with work requirements or prove that they are exempt. New Jersey and West Virginia have created unofficial screening tools to help enrollees determine if they are subject to or exempt from work requirements.

  • New Jersey’s screening tool first asks questions on exemptions. If the user’s information suggests they are unlikely to qualify for an exemption, they are prompted to enter information on their income and current qualifying activity hours.
  • West Virginia’s screening tool only checks for exemption status. If a user selects an option that suggests an exemption, the tool ends and tells the user that work requirements may not apply to them. However, there are no questions on medical frailty, so the screener misses an important potential exemption.
  • Other states that have launched screening tools include Louisiana and Wisconsin.

Broad Outreach

Although not required, some states plan to conduct broader outreach in the fall that will include social media posts, paid media ads, billboards and ads on public transportation, as well as road shows and in-person events. A challenge with broad outreach strategies is to be clear about which Medicaid enrollees are subject to work requirements to avoid confusion among enrollees who are not affected. Work requirements will only apply to adults ages 19-64 in the Medicaid expansion group and in certain Medicaid waiver programs. States are required to exempt many groups from work requirements, including individuals who are pregnant or postpartum, those who are medically frail, and parents /caretakers of dependent children under age 14 or individuals with disabilities. Explaining which parents will be subject to work requirements offers an example of the communication challenges states will face as they develop broad outreach messages. While many parents enrolled in Medicaid are covered through a mandatory parent eligibility pathway and do not have to meet the new requirements, some parents with children over age 13 are covered through the expansion pathway and will be subject to the new requirements (although the share of parents who will have to meet the requirements varies by state). However, because most parents do not know how they are covered, states will need to carefully craft outreach materials to explain who is subject to the new requirements without alarming and creating confusion among those parents who do not have to meet the requirements.

  • New Mexico is planning a paid media campaign including radio ads, digital displays, newspaper ads, and billboards. They also plan to shoot and produce a video commercial on eligibility changes from the 2025 reconciliation law.
  • Similarly, Rhode Island plans to use social media, community partner newsletters, paid media, and local media to get the word out about the Medicaid changes.
  • DC plans to launch an advertising campaign, including ads on public transportation and will also conduct “on the ground” outreach by participating in health fairs and other city events.
  • Montana and New Mexico have planned roadshows across the state.


Provider, Plan, and Community Based Organization Outreach

Providers, health plans, and community organizations generally have more direct interaction with enrollees than staff at a state Medicaid agency and help amplify enrollee outreach. MCO staff, providers, community-based organizations, and navigators/enrollment assisters often help communicate eligibility changes to enrollees.During the unwinding of the continuous enrollment provision, states utilized partnerships with other groups to amplify outreach to enrollees. A few states mentioned drawing on lessons learned from their unwinding experience.

Many states are conducting webinars and developing toolkits for partners to learn more about how work requirements will be implemented, and how to help enrollees navigate the changes. At the time of MAC meetings, some webinars had already been conducted, while others were still being planned. States are also developing various resources with entities that serve Medicaid enrollees that they can share with enrollees. Resources include one-pagers, FAQs, social media graphics, flyers and posters for community spaces. For example,

  • Illinois has launched a webinar series that includes different modules on eligibility changes from the 2025 reconciliation law, including modules on work requirements, exemptions from work requirements, common questions, and systems changes.
  • Montana has conducted partner briefing webinars with education about work requirements, reminders of existing processes on change reporting and notices, and specific information on how community organizations and providers can assist enrollees. Montana sent a notice to providers in May inviting them to a webinar and sharing the Medicaid agency’s provider contact information.
  • Maryland is conducting outreach for employers of Medicaid enrollees, highlighting that employers can play an important role in helping their employees access trusted information by directing employees to official updates and resources.

Some states have highlighted efforts to engage and collaborate with community partners and solicit feedback on implementation issues and outreach to enrollees. States have conducted workshops and working groups to gather feedback from trusted partners, particularly on what messaging works best for enrollees. For example:

  • Utah convened a Community Partner Engagement Group to prepare advocates to help Utahns navigate eligibility changes. The group will develop co-branded outreach materials, synchronize messaging across agencies, and provide an escalation path for partners to resolve issues.
  • Nevada is planning a public workshop to review the state’s communications plan.

The interim final rule allows states to utilize MCOs to assist with outreach and education. In particular, the rule describes how MCOs can help enrollees participate in work programs administered at American Job Centers, which count as hours for compliance with work requirements. MCOs may provide education to enrollees on how to prepare and collect documents for work program appointments and can coordinate with work programs to enable MCOs to follow up with enrollees.

KFF Health Information and Trust Polling Dashboard

Key insights and trends from KFF’s polling on Health Information and Trust

Last Updated:

July 23, 2026

Trusted Sources of Health Information

Who the Public Trusts For Health Information

Copy link to Who the Public Trusts For Health Information

Doctors and other health care providers are the public’s most trusted source of health information, while trust in government health agencies and officials is much more divided. A large majority of adults express at least “a fair amount” of trust in their doctor for reliable information about health issues, while half say they trust the CDC or FDA and fewer than half express trust in their state government officials, HHS Secretary Robert F. Kennedy, Jr., or President Trump.

Partisanship shapes who the public trusts for health information, especially when it comes to Secretary Kennedy and President Trump. Roughly six in ten Republicans, rising to at least seven in ten among MAGA-supporting Republicans, say they trust Secretary Kennedy or President Trump for reliable health information compared to three in ten or fewer independents and Democrats who say the same. On the other hand, Democrats are more likely than Republicans to trust their state officials for health information, while similar shares of Democrats and Republicans say they trust the CDC or FDA. Individual health care providers are the most-trusted source for health information across partisanship.

Across demographic groups – including age, gender, race and ethnicity, and education – health care providers remain the most trusted source of health information. For other health information sources, trust can vary by different groups. White adults and those with a college degree are more likely to express trust in their doctor or health care provider, which may reflect health care access issues. Trust in the CDC and state government officials also differs by education, with college-educated adults more likely to express trust in these sources. White adults are more likely than their peers to express trust in Secretary Kennedy and President Trump for health information.

Confidence in Federal Health Agencies

Copy link to Confidence in Federal Health Agencies

Most of the public lacks confidence in agencies like the CDC or FDA to carry out many of their core responsibilities. While Democrats are somewhat more likely than Republicans to have at least “some confidence” in government health agencies to ensure vaccine safety and effectiveness and make recommendations about the childhood vaccine schedule, fewer than half across partisans have confidence in these agencies to make decisions based on science. For more information, see KFF’s January 2026 Tracking Poll on Health Information and Trust.

Fewer Than Half the Public and Partisans Are Confident in Government Health Agencies To Make Decisions Based on Science (Bar Chart)

Less than half of the public and partisans express at least “some confidence” in the CDC, FDA, or EPA to act independently without outside interference. Democrats are somewhat more likely to say they have confidence in the CDC to act independently, with almost half expressing confidence. On the other hand, four in ten or fewer adults and partisans express confidence in the independence of the FDA or the EPA. For more information, see KFF’s April 2026 Health Tracking Poll.

Fewer Than Half the Public Have Confidence in the CDC, FDA, or EPA To Act Independently Without Interference from Outside Interests (Split Bars)

Trends in Trust of Government Health Agencies and Officials

Copy link to Trends in Trust of Government Health Agencies and Officials

At the onset of the COVID-19 pandemic, there were high levels of bipartisan trust in information about the new virus from the U.S. Centers for Disease Control and Prevention (CDC). Trust in the agency for information about COVID-19 vaccines, and vaccines more generally, subsequently declined amid widening partisan divisions and large drops in Republican trust. Democratic trust in the agency has since declined significantly following President Trump’s reelection and the confirmation of Robert F. Kennedy Jr. as HHS Secretary. Amid these partisan shifts, half of the public now express trust in the CDC for reliable vaccine information. Keep scrolling to see trends among the public and partisans.  

KFF polling has found trust in vaccine information from other health agencies and officials has also declined amid partisan divisions since 2020, including for the U.S. Food and Drug Administration (FDA), state government officials, and local public health departments. 

Who Parents Trust for Childhood Vaccine Information

Copy link to Who Parents Trust for Childhood Vaccine Information

Among parents of children under age 18, pediatricians are the most trusted source of reliable vaccine information. Smaller shares, but still majorities, also trust their local public health department, the CDC, and the FDA. Over half of parents trust their friends and family for vaccine information, while far fewer express trust in Robert F. Kennedy Jr., pharmaceutical companies, or health and wellness influencers. As with the public overall, partisanship plays a role in who parents trust for vaccine information. For more information, see the KFF/Washington Post Survey of Parents.

Among parents, Secretary Kennedy garners trust on vaccines from a majority of Republican supporters of the Make America Great Again, or MAGA, movement (18% of all parents) and supporters of the Make America Healthy Again, or MAHA, movement (38% of all parents). While slim majorities of these MAGA and MAHA parents trust Kennedy for vaccine information, larger shares express trust in their child’s pediatrician.

News, Social Media, and AI

Use and Trust of News Sources for Health Information

Copy link to Use and Trust of News Sources for Health Information

KFF’s Health Misinformation Tracking Poll Pilot measured the public’s consumption of a variety of television, print, radio, and digital news media sources as well as their trust in these sources for information about health issues. Overall, few adults both regularly consume most news sources and trust them a lot for information on health issues, with local and network television news topping the list. Nearly a quarter (23%) of adults say they regularly watch their local TV station and would trust it “a lot” for health information, while a similar share (21%) say the same about national network news. Other news sources, including NPR, CNN, Fox News, local newspapers, The New York Times, digital news aggregators, and MSNBC have trusting audiences that make up between one in ten and one in six of the overall public.    

Stacked bar chart showing percent who say they would trust information about health issues "a lot" and "a little" if they were reported by specific news sources.

Social Media Use for Health Information

Copy link to Social Media Use for Health Information

About three in ten adults say they use social media to find health information and advice “at least monthly,” including larger shares of younger adults, Black and Hispanic adults, lower income adults, and those with lower educational attainment. For more information see KFF’s June 2026 Tracking Poll on Health Information and Trust.

Stacked bar chart showing how often U.S. adults report using social media. Results shown by age gender, race/ethnicity, and party ID.

About one-third of adults who use social media for health information say a “major reason” they turned to social media for health advice was because they wanted to learn from people with similar experiences or because they wanted immediate information or support. About one in six users cite difficulty accessing or affording health care as a major reason.  

Learning From People Who Share Similar Health Experiences Is a Top Reason Adults Use Social Media for Health Information and Advice (Stacked Bars)

Similar shares of adults who use social media for health information or use AI chatbots for health information cite difficulties accessing or affording health care as major reasons they turned to these tools for health advice. These reasons are more commonly cited among lower income social media and AI users. For additional information on use of AI for health information, see AI and Health Information section below.

Similar Shares of Adults Who Use Social Media or AI for Health Information Say Not Having a Regular Provider Was a Reason for Using These Tools (Stacked Bars)
Among Adults Who Use Social Media or AI For Health Information, Those With Lower Incomes Are More Likely To Cite Access and Affordability Issues as a Major Reason (Split Bars)

While fewer than half of the public report actively using social media at least monthly to find health information and advice, larger shares report being exposed to such information in the past month, with majorities saying they have recently seen content related to weight loss, diet, or nutrition and mental health.

While four in ten social media users say they regularly get information about news and politics from social media influencers, far fewer (15%) say they turn to influencers for health information and advice. Younger adults, Black adults, and more frequent social media users are more likely than their peers to say they rely on influencers for health information. For more information on the relative impact of influencers on the public and health policy debates, see KFF CEO Drew Altman’s column.

Split bar chart showing the share of U.S. adults who report regularly getting health information and advice and news about politics from influencers on social media. Results by age gender, party ID, and social media use.

Trust in Social Media for Health Information

Copy link to Trust in Social Media for Health Information

Across different social media platforms, fewer than half of users say they find at least “some” of the health information they see on these platforms to be trustworthy. Younger users tend to be more trusting than older users of health content on certain platforms including TikTok, YouTube, Instagram, and Reddit.

AI and Health Information

Copy link to AI and Health Information

About a third (32%) of the public reports turning to AI chatbots for health information and advice in the past year – rivaling social media as a health information source, but less common than reliance on health care providers or internet search engines (where they may be encountering AI generated results, even if they are not looking for them). The share of adults using AI for health information includes three in ten who say they’ve used these chatbots in the past year for information or advice about their physical health, and one in six who’ve used them for mental health information or advice. For more information, see KFF’s March 2026 Tracking Poll on Health Information and Trust.

Split bar chart showing percent who have sought information or advice about their physical or mental health from specific sources in the past year.

Larger shares of younger adults report turning to AI for either physical health or mental health information in the past year. When it comes to mental health advice, uninsured adults and Black and Hispanic adults are more likely than insured adults and White adults to have turned to AI.

People report using AI for either physical health or mental health information in a variety of ways, most commonly to look up symptoms or general information about health conditions. Fewer say they used AI to help make decisions about whether to seek medical care for either physical or mental health concerns.

Bar chart showing percent who say they have used artificial intelligence tools for information and advice about their physical health in the past year, and whether they have used it for specific reasons.

The most common reason people cite for turning to AI for health advice is wanting quick or immediate support. Many also cite wanting to look up information before seeing a provider or feeling more comfortable looking up health questions privately. One in five cite health care access or affordability issues as major reasons for turning to AI for health questions, including larger shares of younger adults and those with lower household incomes

Among the public overall, few adults say they trust AI tools to provide reliable information about health, but most adults who have used AI for health information and advice say they trust these chatbots to provide reliable health information.

Split bar chart showing trust in AI tools to provide reliable information about health and mental health respectively. Results shown by total adults and by use of AI for different types of health information.

False or Unproven Health Claims

Awareness and Belief in False or Unproven Health Claims

Copy link to Awareness and Belief in False or Unproven Health Claims

Exposure to health misinformation is often widespread, but relatively small shares of the public express certainty that many false or unproven claims are true. In fact, at least half of the public fall in a “malleable middle,” saying these claims are either “probably true” or “probably false.” The public’s uncertainty around false or unproven health claims related to COVID-19 , vaccines , measles  and the purported causal link between Tylenol and autism presents an opportunity for interventions to clear up confusion and deliver accurate information.

Measuring Exposure

Copy link to Measuring Exposure

KFF polls have measured exposure to a wide array of false, misleading, and unproven health claims since 2023. Exposure varies widely depending on the topic and prominence of news coverage of the claim. The most widely heard of those tested in KFF polls is that taking Tylenol during pregnancy increases the risk of a child developing autism, a claim cited by President Trump in a widely covered September 2025 press conference.

The Malleable Middle

Copy link to The Malleable Middle

Across an array of false or unproven health claims measured in KFF surveys, few adults are certain these claims are “definitely true” while much larger shares say they are “definitely false.” For most claims, at least half express uncertainty, falling into the malleable middle and saying the claims are either “probably true” or “probably false.” Six recent false claims measured in 2026 and 2025 KFF surveys are shown below.

While Few Adults Think False or Unproven Health Claims Are Definitely True, Many Express Uncertainty (Stacked Bars)

Typology of Belief Across Vaccine Myths

Copy link to Typology of Belief Across Vaccine Myths

While KFF polling has consistently found that much of the public falls in the “malleable middle” when it comes to a wide array of false health claims, there are nuances within this group that can be examined by looking at patterns of belief across multiple myths. KFF’s June 2026 Tracking Poll on Health Information and Trust identified five groups based off patterns of belief across four common vaccine myths:

KFF polling has measured exposure to and belief in false or unproven claims across a wide array of topics. For information on belief in additional claims about COVID-19, reproductive health, and gun violence, see KFF’s Health Misinformation Tracking Poll Pilot.  For information on additional false claims related to COVID-19, see KFF’s May 2022, and October 2021 COVID-19 Vaccine Monitors.

Belief in False or Unproven Health Claims

Copy link to Belief in False or Unproven Health Claims

KFF polling has found partisanship and education play a substantial role in belief of false or unproven health claims about vaccines, COVID-19 and measles. Republicans and adults without a college degree are consistently more likely than Democrats and college educated adults, respectively, to believe or lean towards believing vaccine-related myths. For more information, see KFF's June 2026 Tracking Poll on Health Information and Trust.

Beyond partisanship and education, belief in common vaccine myths sometimes varies by age and race and ethnicity. Larger shares of adults ages 30-49 compared to older adults say false claims about vaccines are either definitely or probably true, as do Black adults compared to White adults. Hispanic adults are more likely than White adults to endorse two false claims about the measles vaccines. These differences show that susceptibility to health misinformation among some groups can vary depending on the topic, which may reflect different information channels relied upon by these groups (see social media and news sources sections for more information).

Adults who frequently use social media or artificial intelligence (AI) tools for health information are more likely to say several false claims about vaccines are definitely or probably true, as are those who lack a trusted health care provider compared to those who have a provider they trust to answer questions about their health.

Appendix For False or Unproven Health Claims

Copy link to Appendix For False or Unproven Health Claims

KFF polling has sought to examine the public’s exposure to and belief in a wide array of false or unproven health claims. Many of the false or unproven claims measured in KFF surveys have been amplified by or directly made by government officials, while others have been more nebulously shared and spread in public media over the years. Below is a list of sources to document these claims’ inaccuracy.

Table

Vaccine Attitudes

Views on Vaccine Safety Among the Public

Copy link to Views on Vaccine Safety Among the Public

Most U.S. adults, including majorities across partisans, express confidence in the safety of many routine vaccines for children, including MMR, polio, and hepatitis B. Similarly, large majorities of adults ages 50 and over are confident that vaccines for pneumonia and shingles are safe. Views on the safety of COVID-19 and flu vaccines for both adults and children are more divided, with large shares of Democrats expressing confidence compared with smaller shares of Republicans. For more information, see KFF’s June 2026, January 2026 and April 2025 Tracking Polls on Health Information and Trust.

Parents’ Vaccine Attitudes and Behavior

Copy link to Parents’ Vaccine Attitudes and Behavior

In summer 2025, large majorities of parents expressed confidence in the safety of childhood vaccines for polio and measles, mumps, and rubella (MMR), but parents’ views on the safety of flu and COVID-19 vaccines were more polarized. About two-thirds of parents say the flu vaccines are safe for children, while fewer than half say the same about COVID-19 vaccines, with divisions along partisan lines. Beyond partisanship, parents who support the Make America Healthy Again (MAHA) movement (38% of parents), Black parents and parents under age 35 are less likely than their peers to be confident that many routine vaccines are safe for children. For more information, see the KFF/Washington Post Survey of Parents.

Majorities of Parents Are Confident in the Safety of Childhood Polio and MMR Vaccines, but Vaccines for COVID-19 and the Flu Are Divisive (Split Bars)

Most parents report keeping their children up to date on childhood vaccines, but about one in six say they have ever skipped or delayed at least one childhood vaccine for any of their children (excluding seasonal vaccines like flu and COVID-19). Despite strong uptake, many parents express skepticism towards vaccine safety testing and the number of vaccines recommended by the CDC (this survey was fielded prior to recent changes to the childhood vaccine schedule announced by HHS in January 2026). Younger parents and those who identify as Republicans are more likely than their counterparts to endorse vaccine-skeptical attitudes and to report skipping vaccines for their own children. For more information, see the KFF/Washington Post Survey of Parents.

Split bar chart showing percent who say specific false claims about vaccines and diseases are true. Results shown by total parents, parents by vaccine choice, party identification, and support for MAGA.

Parents who skip or delay recommended vaccines for their children are about twice as likely as parents who keep their children up to date on vaccines to believe or lean toward believing false claims about the measles and COVID-19 vaccines, underscoring how false health claims may shape parents’ decisions. For more information, see KFF's June 2026 Tracking Poll on Health Information and Trust.

Split bar chart showing share of U.S. adults who say they believe about each of three false claims related to measles.

mRNA Vaccine Safety

Copy link to mRNA Vaccine Safety

COVID-19 vaccines and some other vaccines currently under development rely on a vaccine technology known as messenger-RNA (mRNA), which has long been the subject of misinformation. While few adults view mRNA technology as unsafe, the technology remains obscure to much of the public, with about half saying they don’t know enough to say. For more information, see KFF’s April 2025 Tracking Poll on Health Information and Trust.

Stacked bar chart showing how safe U.S. adults, by partisanship, think mRNA technology in vaccines is.

VOLUME 51

New KFF Poll Shows Public Divided When It Comes to Trusting Federal Health Agencies for Reliable Information


Highlights

KFF’s latest Tracking Poll on Health Information and Trust finds that following large declines in trust in federal health agencies from 2020 through early 2026, trust in the CDC as a source of health information held steady over the last 6 months, while trust in both President Trump and state government officials declined somewhat. These findings, including levels of trust in sources of health information broken out by key demographic groups, can also be found on KFF’s interactive Health Information and Trust Polling Dashboard.


KFF polling over the past several years has documented declining trust in the U.S. Centers for Disease Control and Prevention (CDC) for vaccine information, beginning during the COVID-19 pandemic and continuing during the first part of President Trump’s second term. As Congress considers President Trump’s nomination of Erica Schwartz to lead the CDC, the latest KFF poll finds that about half of the public (51%) express at least a fair amount of trust in the CDC to provide reliable health information, similar to the share who said so in January. The same share (51%) express trust in the FDA, also steady since January. Trust is lower for other sources, with fewer than half of adults saying they trust their state government officials, HHS Secretary Robert F. Kennedy Jr., or President Trump to provide reliable health information. The share who trust state government officials for health information is down 5 percentage points since January (38%, down from 43%), while trust in President Trump has declined by a similar amount (24%, down from 30%).

Doctors continue to be the public’s most trusted source of reliable information on health issues, with a large majority of adults (86%) saying they have at least “a fair amount” of trust in their own doctor or health care provider, similar to the share who said so in January.

Stacked bar chart showing percent who say they trust specific people and institutions a great deal, a fair amount, not much, or not at all to provide reliable information about vaccines.

Doctors and health care providers stand out as the one source trusted by large majorities of Democrats, independents, and Republicans alike. However, when it comes to some other sources of health information, partisans diverge. About six in ten Republicans say they trust Secretary Kennedy (64%) and President Trump (61%) for reliable health information, compared to three in ten or fewer independents and Democrats who say the same. On the other hand, Democrats (50%) are more likely than independents (35%) and Republicans (34%) to trust their state government officials for health information. Democrats were much more likely than Republicans to trust the CDC and FDA for vaccine-related information throughout Joe Biden’s presidency, but partisan gaps have narrowed during President Trump’s second term. Similar shares of Democrats (52%) and Republicans (56%) now say they trust the FDA for reliable health information, while Democrats remain just slightly more likely than Republicans to express trust in the CDC (58% vs. 49%).

Stacked bar chart showing percent who say they trust specific people and institutions a great deal, a fair amount, not much, or not at all to provide reliable information about vaccines.

AI & Emerging Technology

State Laws Regulating AI Chatbots and Mental Health Take Different Paths

A United Nations (UN) scientific panel’s preliminary report, released earlier this month, describes both the promise of the use of AI for health care and serious risks, particularly in conversations about mental health. The report warns that AI systems designed to be highly agreeable can validate a user’s beliefs regardless of accuracy, and in some cases, deepen emotional dependency or reinforce harmful thinking. The panel recommended legal incentives for safer system design, stronger evaluations of how these systems behave, and accountability measures for when they cause harm.

As AI chatbots and companions are increasingly becoming a source of mental health information and advice, states are already moving on these questions, but not in the same direction:

Why This Matters: As state governments consider different regulatory responses to the growing use of AI chatbots and AI companions, a March KFF Tracking Poll on Health Information and Trust found that one in six adults say they have used AI for information and advice about their mental health or emotional wellbeing in the past year. Younger adults are particularly likely to be turning to AI for mental health information, with nearly three in ten (28%) of those between the ages of 18 and 29 saying they have done so in the past year.

A new Minnesota law was scheduled to take effect July 1, requiring social media platforms including TikTok, Facebook, and Instagram to display warnings about the potential mental health risks of social media use, along with information for the 988 Suicide and Crisis Lifeline. Lawmakers say the law is intended to prompt users, particularly young people and parents, to think about their time on these platforms. An industry group representing social media companies sued to block the law, arguing that the mandated messages amount to compelled speech, and the state’s attorney general has agreed not to enforce it while the lawsuit is pending. A similar law in Colorado was put on hold last year after a comparable legal challenge. These laws target the potential risks of social media broadly rather than specific content, joining other efforts that allege platform design itself, not just the content posted on social media, can pose mental health risks to users.


What We're Watching

Social Media Health Information is Widely Distrusted, but Still Shapes Decisions

Most U.S. adults engage with health content on social media in some form, whether by sharing it or participating in online health communities, according to a new research letter published in JAMA reporting results from the 2024 Health Information National Trends Survey. Most users also said they don’t trust what they see there: 78% of users reported believing that health information on social media was false or misleading.

More recent KFF polling from June 2026 supports these findings, with about three in ten adults (31%) now using social media at least monthly for health information and advice. A majority (61%) say they are confident they are able to tell what’s true or false, but only about a third of social media users (36%) say they follow up with a doctor at least most of the time to check what they’ve seen.

The JAMA research letter goes further, though, examining whether people act based on what they see. More than one in five adults who use social media (21.6%) said they had made at least one health-related decision based on something they saw on these platforms. The letter’s authors note that these findings describe patterns of engagement rather than the accuracy of the content itself, with social media functioning as a widely used, if often distrusted, source of health information that still shapes behavior.

Why This Matters: The findings taken together show that social media content can still influence health decisions, regardless of how confident people feel in their own judgment or how skeptical they say they are. Although the underlying data in the JAMA letter is from 2024, KFF will continue to monitor how distrusted sources of health information may impact behavior, particularly as the AI and social media landscapes continue to evolve.

Misleading Sunscreen Content Is Rare on TikTok, But Outsized Engagement Keeps It Visible

A content analysis of 971 of the most-viewed TikTok videos using popular sunscreen-related hashtags, published last month in PLOS Digital Health, found the vast majority (86.8%) of sunscreen-related content promoted its use, commonly highlighting protection against skin damage, acne, aging, and cancer. A small share of videos (6.0%) included critique of sunscreen, and an even smaller fraction (1.6%) solely discouraged its use. While overall view counts did not differ significantly between content types, videos that only critiqued sunscreen received significantly higher engagement in likes, shares, and comments than promotional videos, suggesting that a small volume of content can still reach audiences disproportionately to its actual share of posts.

The study identified several specific claims among the small number of critical videos, including that sunscreen is toxic, contains carcinogens, disrupts hormones, or prevents the body from gaining the benefits of sun exposure, including vitamin D production. Multiple studies have found that regular sunscreen use does not cause vitamin D deficiency, and the chemical ingredients most often singled out in online criticism have no indication of being harmful to human health at the concentrations used in approved products.

Many of these claims have circulated online for several years, in some cases tracing back to a 2020 study finding that some chemical sunscreen ingredients are absorbed into the body at levels exceeding the FDA’s threshold for further safety testing. That finding on its own, though, does not indicate that an ingredient is unsafe. Some posts have also conflated past recalls of specific sunscreen products found to contain benzene, an unrelated and unapproved contaminant, with the safety of approved active ingredients generally. As a new sunscreen ingredient approved by the FDA last month begins appearing in U.S. products, KFF will monitor whether confusion about sunscreen ingredient safety continues to affect how the public perceives and uses sunscreen.

Why This Matters: The influence of misleading claims about sunscreen safety may lie less in their overall volume than in how strongly they resonate with the audiences who do encounter them. KFF polling has found that nearly four in ten (39%) of adults are “not too” or “not at all” confident in their ability to tell what is true or false in health information they see on social media. Such uncertainty may leave more room for a small volume of highly engaging false claims to carry influence beyond what their limited presence may suggest.

About The Health Information and Trust Initiative: the Health Information and Trust Initiative is a KFF program aimed at tracking health misinformation in the U.S., analyzing its impact on the American people, and mobilizing media to address the problem. Our goal is to be of service to everyone working on health misinformation, strengthen efforts to counter misinformation, and build trust. 


View all KFF Monitors

The Monitor is a report from KFF’s Health Information and Trust initiative that focuses on recent developments in health information. It’s free and published twice a month.

Sign up to receive KFF Monitor
email updates


Support for the Health Information and Trust initiative is provided by the Robert Wood Johnson Foundation (RWJF). The views expressed do not necessarily reflect the views of RWJF and KFF maintains full editorial control over all of its policy analysis, polling, and journalism activities. The data shared in the Monitor is sourced through media monitoring research conducted by KFF.

Abortion Trends Before and After Dobbs

Published: Jul 22, 2026

Editorial Note: This brief was updated on July 22, 2026, to incorporate new data on abortion statistics.

  • In the years following the Supreme Court ruling that overturned Roe v. Wade, the volume of abortions nationally has slightly increased. The most recent data from the Society for Family Planning’s #WeCount project show that the average monthly abortion volume in 2025 was higher than the monthly average in 2024. From January to December 2025, there have been 1.13 million abortions compared to 1.11 million abortions in all of 2024 and 1.05 million abortions in 2023. For most of the decade prior to the Dobbs ruling, there was a steady decline in abortion rates nationally, with a slight uptick in the years just before the ruling.
  • The upward trend in abortion volume is likely due to multiple reasons, including expanded telehealth capacity, the ability to mail medication abortion pills to patients, and the lower costs for telehealth abortions through virtual clinics compared to in-person care. Medication abortion via telehealth now accounts for 28% of all abortions.
  • In contrast to the bans on the provision of abortion, several states have passed laws to protect and expand abortion access. Twelve (12) states require state-regulated private plans to cover abortion, many without cost-sharing, and 20 Medicaid programs use state-only funds to cover nearly all medically necessary abortions. Twenty-three (23) states passed shield laws intended to reduce the legal risks for clinicians who provide abortion care to patients who live in states where abortion is banned or restricted.
  • Interstate travel for abortion has also increased. The travel rate for abortion care across state lines nearly doubled from 2020 to 2024, with Illinois, North Carolina, New Mexico, and Kansas experiencing the highest volume of out-of-state abortion patients last year.
  • The CDC, which historically collected abortion information from most states, has not published any new abortion surveillance data since the second Trump Administration began. The most recent data was collected in 2022, the same year as the Dobbs ruling.

Following the 2022 ruling in Dobbs v. Jackson Women’s Health Organization, it was generally expected that the abortion rate would drop due to the number of states that rapidly adopted abortion bans (13 states) and early gestational restrictions (6 states). There is no doubt these policies have made abortion access much more challenging or even impossible for those seeking abortion who live in restrictive states; yet, contrary to expectations, recent data show that the volume of abortions in the U.S. overall has slightly increased in three years following the Supreme Court ruling. The combination of growth in telehealth availability for abortion care, lower telehealth costs, increased legal reproductive health care protections through state efforts, and higher rates of interstate travel, all likely contributed to the unexpected trajectory in abortion volume. However, the possibility of more state bans and restrictions combined with the ongoing legal challenges seeking to further restrict access may reverse this trend. Additionally, future actions that the Trump administration could take at the federal level could further limit abortion availability and access even in states that have enshrined the right to abortion, particularly if the administration restricts the distribution of medication abortion pills through the Comstock Act or targets the provision of telehealth abortions through regulatory revisions at the Food and Drug Administration.

This brief reviews the different sources of abortion data in the U.S., the factors that have affected abortion rates across the country before and after Dobbs, and what we may see as the Trump administration, Republican majorities in the House and Senate, and a conservative federal judiciary shape policy in the coming years.

How is abortion tracked at the state and federal level?

Three major organizations collect and report national and state-level data on abortion volume and rates: the federal Centers for Disease Control and Prevention (CDC), the Guttmacher Institute, and most recently, the Society of Family Planning through its (SFP) #WeCount project. 

For decades, the federal CDC Abortion Surveillance System has requested data from the central health agencies of the 50 states, D.C., and New York City to document the number and characteristics of women obtaining abortions. Reporting to the CDC is voluntary and not all states participate in the surveillance system. Notably, California, Maryland, and New Hampshire have not reported data on abortions to the CDC system for years. Most states collect and report data on the demographic characteristics of patients, gestational weeks, and type of abortion procedure. CDC publishes data from the surveillance system annually, with the most recent data on abortions in 2022, reflecting a 2-year lag. Since the second Trump Administration began, the CDC has not issued any new surveillance data on abortion, and the federal staff from the agency’s Reproductive Health Division were terminated.

Prior to the Dobbs ruling, the Guttmacher Institute, an independent research and advocacy organization, periodically conducted the Abortion Provider Census (APC), collecting data on abortion incidence and abortion facilities. Data from the APC are based primarily on questionnaires completed by known facilities that provide abortion in the country, information from state health departments, and Guttmacher estimates for a small portion of facilities. The most recent APC reports data from 2020. Following the Dobbs ruling, the Guttmacher Institute established an additional data collection initiative, the Monthly Abortion Provision Study, to track abortion volume within the formal U.S. health care system. This ongoing effort collects data on and provides national and state-level estimates on abortions while also tracking the changes in national abortion volume since 2020.

While the CDC and Guttmacher APC data differ in terms of collection methods, timeframe, and completeness, both have shown similar trends in abortion rates over the past decade. One notable difference is that Guttmacher’s survey has included continuous reporting from all states, which explains at least in part the higher abortion volume in their data.

Society of Family Planning’s (SFP) #WeCount is a newer national reporting initiative that measures changes in abortion volume following the Dobbs ruling. The project provides semiannual reports on the monthly number of abortions by state and includes data on abortions provided through in-person health care settings and through telehealth. The #WeCount report started collecting data in April 2022 and has published three full years of abortion data since Dobbs.

Comparison of Major Abortion Data Sources in the United States (Table)

How many abortions occurred prior to the Dobbs ruling?

For most of the decade prior to the Dobbs ruling, there was a steady decline in abortion rates nationally, but there was a slight increase in the years just before the ruling.

The most recent CDC data are from 2022, the same year as the Dobbs decision, and show that abortion rates declined from 2013 through 2017 and remained steady in the years leading up to the court decision (Figure 1). CDC reported 609,360 abortions in 2022 and a rate of 11.2 abortions per 1,000 women (excludes CA, DC, MD, NH, and NJ). In contrast, the Guttmacher Institute reported 930,160 abortions in 2020 and a rate of 14.4 abortions per 1,000 women. Guttmacher’s study showed a slight upward trend in abortion from 2017 to 2020 whereas CDC’s report showed a stable rate in abortions from 2017 to 2022 except for a slight uptick in 2019 and 2021.

Experts generally attribute the long-term decline in abortion rates to increased use of more effective methods of contraception. The slight increase in the years leading up to the Dobbs decision could be due to greater state-level coverage of Medicaid enrollees that made abortion access more affordable in some states as well as broader financial support from abortion funds to help individuals pay for the costs of abortion care.

Before the Dobbs Decision, the Number of Abortions Had Started to Rise Slightly Following a Decade-Long Decline

Even prior to the Dobbs ruling, abortion rates varied widely between states.

National averages can mask local and more granular differences. Some of the variation in abortion volume and rates has been due to the wide differences in state policies that have shaped the availability of abortion, with some states historically placing restrictions on abortion (such as targeted regulations of abortion providers, requirements for multiple visits, and mandatory waiting periods), that constrained abortion access and availability. In some states, there were only one or two abortion clinics even before Dobbs.

Abortion Rates Varied Widely by State Prior to the Dobbs Decision

What has happened to abortion volume since Dobbs?

The SFP and Guttmacher Institute data both find that while the number of abortions in the U.S. dropped immediately following Dobbs, the total number or volume of abortions nationally has increasedthree full years following the ruling. However, the consistency observed at the national level obscures wide state-level variation and sharp declines in abortion volume in states with bans and early gestational restrictions.

The latest SFP’s #WeCount data show that there were 1.13 million abortions performed or pills distributed in 2025. There were 1.11 million abortions in 2024, slightly up from 1.05 million in 2023. The monthly average abortions steadily increased from 85,780 abortions per month in 2023 to 92,400 abortions in 2024 to 93,900 in 2025 (Figure 3).

While the Overall Number of Abortions in the U.S. Increased in the Three Years After Dobbs, There is Great Variation Between States That Permit and Ban Abortion (Line chart)

Why did abortions increase after states instituted bans?

While it was not a total surprise that states without abortion bans had an increase in abortions following the Dobbs ruling, the reasons behind this increase are complex. The upward trend is likely due to a combination of increased interstate travel for abortion access by people coming from abortion ban states, the presence of state-level laws in states that protect providers who offer abortion services, lower costs associated with telemedicine medication abortions, and expanded virtual/telehealth capacity and the ability to mail medication abortion pills to patients from both bricks-and-mortar and telemedicine-only providers.

The Rise of Medication Abortion, Telehealth, and Virtual Clinics

While procedural abortions are only performed in a clinical setting, medication abortion can be provided either in a clinical setting or remotely via telehealth. Medication accounts for nearly two thirds (65%) of abortions nationally. Approved by the U.S. Food and Drug Administration (FDA) in 2000, mifepristone, one of the drugs used for medication abortion, has a solid safety and effectiveness record regardless of whether the pills are dispensed in person by a clinician (either medical doctor or advanced practice clinician) or via telehealth and mailed or dispensed through a retail pharmacy. When taken, medication abortion successfully terminates the pregnancy 91.9% to 99.7% of the time, with a 0.4% risk of major complications, and an associated mortality rate of less than 0.001 percent (0.0005%). The latest Guttmacher data show that in states without bans, medication accounted for the majority of abortions in 2023 (Figure 4). In five states (MT, WY, NE, GA, and VT), more than eight in ten abortions were medication abortions.

Medication Abortion Accounted for the Majority of Abortions in 2023 in States Without Bans

Access to medication abortion via telehealth had been historically limited by an FDA policy (Risk Evaluation Mitigation Strategy or REMS) that had permitted only physicians in a health care setting to dispense mifepristone in person. This resulted in a restriction on the ability to mail the pills or for retail pharmacies to dispense. In December 2021, the FDA revised this policy, lifting the requirement that clinicians dispense the drug only in-person. This was done, in part, to alleviate the burden placed on the health care delivery system during the COVID-19 public health emergency. In January 2023, the FDA finalized a policy change that allows retail pharmacies to dispense medication abortion pills to patients with a prescription. These changes opened the door to greater use of telehealth for medication abortions. Subsequently, there was a rise in the number of virtual clinics, which now account for a quarter (24%) of facilities that offer medication abortion services.

The most recent report shows that telehealth abortions accounted for 28% of all abortions in 2025(Figure 5). The #WeCount reports distinguish between telehealth abortions provided by brick-and-mortar facilities from those provided under shield laws that give some legal protections to clinicians who provide abortion care via telehealth to people living in states with bans and restrictive policies. More than half of these telehealth abortions were performed under shield laws (56%), 7% of abortions were from online services offered by clinics that traditionally operate from physical locations (brick-and-mortar facilities), and four in ten (40%) were from virtual-only clinics. The provision of telehealth abortions varies widely across states, ranging from 8% in D.C. to 44% in Nevada. Note: The counts for medication abortions, particularly those provided by mail, reflect the number of pills dispensed by providers, not necessarily complete abortions.

Costs for Telemedicine Abortions

The median price of medication abortion offered through brick-and-mortar clinics increased from $580 in 2021 to $600 in 2023. In contrast, the median price of medication abortions via virtual clinics decreased from $239 in 2021 to $150 in 2023, which is 75% less than the cost of in-person care (Figure 6). Virtual clinics do not incur many of the costs of a physical clinic, such as building maintenance, meeting regulations for surgical centers, and security to handle protesters. The increased availability of telehealth and virtual clinics has lowered the costs of care and reduced financial barriers resulting from abortion services as well as travel and other related expenses.

Costs for some have also been offset by the availability of financial assistance and logistical support from national and local networks of abortion funds. Since Dobbs, these networks received a reported 39% more requests for abortion support and financially supported more than 100,000 individuals seeking abortion care.

Medication Abortion Costs 75% Less When Offered Through Virtual Clinics Compared to Brick and Mortar Clinics

State-Level Protections

Over the past several years, some of the states where abortion remains legal have passed laws to protect abortion access for their residents and expand access to people seeking abortions from other states. For example, residents in California are protected from civil liabilities for providing or receiving abortion services, and providers are protected from professional discipline. Policies that have been implemented include using state funds to cover abortions under Medicaid beyond federal limitations, raising Medicaid reimbursement rates for abortion services, requiring state-regulated private plans to cover abortion, and enacting shield laws to protect clinicians who provide abortions in their states either in person or via telemedicine. 

Today, 12 states require state-regulated private plans to cover abortion, some without any cost-sharing (Figure 7).

State actions to use their own revenues to pay for abortions have also expanded access to abortion services. States are not restricted by the federal Hyde Amendment (which bans the use of federal funds for abortion in Medicaid, Medicare and other public programs unless the pregnancy is a result of rape, incest, or if it endangers the woman’s life) and have the option to use state-only funds to cover abortions under other circumstances for women on Medicaid, which 20 states do currently.

Twelve States Require State-Regulated Private Insurance Plans to Cover Abortion

A growing number of states passed shield laws to reduce the legal risks for clinicians who provide abortion care to patients who live in states where abortion is banned or restricted. While the details of these laws vary state to state, some policies protect clinicians from professional discipline for offering health care that is criminalized in another state, and others protect clinicians who provide care to patients across state lines, such as by prescribing and mailing abortion pills via telehealth services to patients in their state of residence. Some states also passed broader shield laws to protect patients and people assisting with reproductive services from civil and criminal consequences. As of July 2026, 22 states and Washington D.C. have enacted shield laws, with 8 states extending explicit protections to clinicians regardless of patient location or state of residence (Figure 8).

Many States Have Shield Laws for Reproductive Health Care Services

Interstate Travel

The Guttmacher Institute Monthly Abortion Provision Study is the only data source so far to provide in-depth information on interstate travel pre- and post-Dobbs. Guttmacher estimates that prior to Dobbs, nearly one in ten people obtained an abortion by traveling across state lines in 2020. Even though abortion was legal, there were considerable restrictions in many states that made abortion access very limited, which led to the need for interstate travel for abortion care for some people. The latest data show that 142,000 patients traveled out of state for abortion care in 2025, a slight drop from 2024, but notably higher than the number of travelers in 2020 (81,000), before the Dobbs ruling. The states with the highest number of people traveling inbound for abortion care border at least one state where abortion is banned, including Illinois (32,560 patients), North Carolina (17,870 patients), Kansas (13,630 patients), and New Mexico (10,180 patients) (Figure 9).

States With the Highest Number of Inbound Abortion Patients Border at Least One State Where Abortion Is Banned (Choropleth map)

While the data show that abortions slightly increased three years after Dobbs, ongoing and impending legal challenges, state legislative efforts, and federal executive actions could further alter the reproductive care landscape and have impacts beyond abortion counts. A recent JAMA study, for instance, found that fertility rates have increased in states with complete or 6-week abortion bans, namely among populations with the greatest structural disadvantages and barriers to obtaining abortion care. A concurrent study showed infant mortality rates have also risen in these states, many of which are already experiencing some of the worst maternal, infant, and child health outcomes in the U.S. The findings from these studies underscore the widespread repercussions of policy efforts aimed at restricting abortion access.